<SEC-DOCUMENT>0001104659-24-078098.txt : 20240705
<SEC-HEADER>0001104659-24-078098.hdr.sgml : 20240705
<ACCEPTANCE-DATETIME>20240705161751
ACCESSION NUMBER:		0001104659-24-078098
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240705
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240705
DATE AS OF CHANGE:		20240705

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TACTILE SYSTEMS TECHNOLOGY INC
		CENTRAL INDEX KEY:			0001027838
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37799
		FILM NUMBER:		241102786

	BUSINESS ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
		BUSINESS PHONE:		866-435-3948

	MAIL ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2418929d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:TCMD="http://tactilemedical.com/20240705">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_TCMD_tactilemedical.com_20240705 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20240705_20240705 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001027838 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000004" name="dei:EntityCentralIndexKey">0001027838</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-07-05" id="xdx2ixbrl0012" name="dei:EntityRegistrantName">TACTILE SYSTEMS TECHNOLOGY INC</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tcmd-20240705.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-07-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001027838</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-05</xbrli:startDate>
        <xbrli:endDate>2024-07-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20240705__20240705_zSG8Vxj3qwe6"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
<b>&#160;<span id="xdx_909_edei--DocumentPeriodEndDate_c20240705__20240705_z3NR1ounI7I"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">July 5, 2024</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2in 2pt; text-align: center"><b>&#160;</b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_905_edei--EntityRegistrantName_dxL_c20240705__20240705_zaIZEpC9OzDc" title="::XDX::TACTILE%20SYSTEMS%20TECHNOLOGY%20INC"><b><span style="-sec-ix-hidden: xdx2ixbrl0012">TACTILE
SYSTEMS TECHNOLOGY, INC.</span></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2in 2pt; text-align: center">(Exact name
of registrant as specified in its charter)</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>




<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20240705__20240705_zIIOwDQ2lSP"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span id="xdx_904_edei--EntityFileNumber_c20240705__20240705_z8ZniZgt3Ms6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000014" name="dei:EntityFileNumber">001-37799</ix:nonNumeric></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 33%"><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20240705__20240705_z5vMynwdvyyk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000015" name="dei:EntityTaxIdentificationNumber">41-1801204</ix:nonNumeric></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20240705__20240705_zzyIoWhmNNji"><b><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000016" name="dei:EntityAddressAddressLine1">3701
Wayzata Blvd</ix:nonNumeric></b></span><b>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20240705__20240705_zW6xzfTiql2f"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000017" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b><b>,
<span id="xdx_901_edei--EntityAddressCityOrTown_c20240705__20240705_zvfXhSu5oUK7"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000018" name="dei:EntityAddressCityOrTown">Minneapolis</ix:nonNumeric></span></b><b>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20240705__20240705_z1SGqr3wi1Ti"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000019" name="dei:EntityAddressStateOrProvince">MN</ix:nonNumeric>
</span></b><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20240705__20240705_zQUNEnlYclR7"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000020" name="dei:EntityAddressPostalZipCode">55416</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip
Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90C_edei--CityAreaCode_c20240705__20240705_zoNrWMDcq1m3"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000021" name="dei:CityAreaCode">612</ix:nonNumeric></span></b><b>)
<span id="xdx_903_edei--LocalPhoneNumber_c20240705__20240705_z1SEJ8cGkcoh"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000022" name="dei:LocalPhoneNumber">355-5100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_902_edei--WrittenCommunications_c20240705__20240705_zM3KdKRHsSHl" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span>&#160;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_90B_edei--SolicitingMaterial_c20240705__20240705_zQCHjcohavQl" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span>&#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><span id="xdx_900_edei--PreCommencementTenderOffer_c20240705__20240705_z8wc8A3XRMZj" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span>&#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20240705__20240705_z1HkFNdInT4" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span>&#160;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Securities registered
pursuant to Section 12(b) of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which <br/>
    registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20240705__20240705_zEyHdhpznwp6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, Par Value $0.001 Per Share</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--TradingSymbol_c20240705__20240705_zcGifhH0hzzh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-07-05" id="Fact000028" name="dei:TradingSymbol">TCMD</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20240705__20240705_znTQT0ODVmS5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160;<span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20240705__20240705_zc1nK8gpgJw9"><ix:nonNumeric contextRef="AsOf2024-07-05" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span>
Emerging growth company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01. Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-size: 10pt; background-color: white">Pursuant
to the settlement documentation discussed further in Item 8.01 below, a copy of a notice and the stipulation of settlement are furnished
as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form&#160;8-K. The information in Exhibits 99.1 and 99.2 </span>shall
not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934 or otherwise subject to
the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under
the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in that
filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 8.01. </b></span><b>Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On July&#160;5, 2024, Tactile Systems Technology,&#160;Inc.
(the &#8220;Company&#8221;) announced that on June&#160;6, 2024, it entered into a Stipulation of Settlement in the stockholder derivative
lawsuit pending in the United States District Court for the District of Delaware captioned <i>Jack Weaver v. Moen</i>, et al., File No.&#160;1:22-cv-01063-GBW.&#160;
A description of the lawsuit was set forth in the section entitled &#8220;Legal Proceedings&#8221; in <span style="background-color: white">Note
8 &#8211; &#8220;Commitments and Contingencies&#8221; of the condensed consolidated financial statements contained in t</span>he Company&#8217;s
Form&#160;10-Q filed with the Securities and Exchange Commission on May&#160;6, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June&#160;7, 2024, the plaintiff filed an unopposed
motion for preliminary approval of the settlement.&#160; On June&#160;27, 2024, the Court entered an order granting the motion for preliminary
approval of the settlement (the &#8220;Preliminary Approval Order&#8221;).&#160; The Court has scheduled a Settlement Hearing for August&#160;28,
2024 to consider whether to grant final approval to the settlement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the settlement, the Company will adopt,
implement and maintain certain corporate governance reforms and has agreed to file this Form&#160;8-K and provide other disclosures regarding
the settlement. The Company has also agreed to pay approximately $0.5 million in fees and expenses related to this lawsuit. The settlement
does not constitute an admission of liability or wrongdoing by the Company, or any of the Company&#8217;s current or former directors
or officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT&#160;INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/> No.</b></span></td>
    <td style="text-align: center; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 91%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2418929d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2418929d1_ex99-1.htm"><span style="font-size: 10pt">Notice</span> of Pendency of Derivative Action, Proposed Agreement of Settlement and Release, and Settlement Hearing</a></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2418929d1_ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2418929d1_ex99-2.htm">Stipulation of Settlement</a></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TACTILE SYSTEMS TECHNOLOGY,&#160;INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="width: 50%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July&#160;5, 2024</span></td>
    <td style="vertical-align: top; width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 47%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <i>Elaine M. Birkemeyer</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine M. Birkemeyer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin: 0">&#160;</p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WUq3esjHxCKyCInodckxlnRHZrfST+ov25RoGBiGe8+9QoRiQ2tdI8NlVeRwwqatlUMosEJGc0XvSLe7BPwt8KatY2Xc8P7AlDyDnllMpFReGKxPbbFMIJpP4+VUziFaJnIGx70IvnpKptIlGqdVDcqUcGRqWaNT3I8JJ9WRoaYfqs7IVpNJIJ5Eo/wGGcUSDvRUL+K7hTxPRRAOE4gN06P1rqxzaL4kZDU2vs6O9H+DDwsKSpQ= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2418929d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES DISTRICT COURT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DISTRICT
OF </B></FONT><B>DELAWARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">JACK WEAVER, Derivatively on
    Behalf of TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Plaintiff,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">v.</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BRENT MOEN, et al.,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Defendants,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">-and-</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Nominal Defendant.</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P></TD>
    <TD STYLE="width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Case No.&nbsp;</FONT>1:22-cv-01063-GBW</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF PENDENCY OF DERIVATIVE ACTION, PROPOSED<BR>
<U>AGREEMENT OF SETTLEMENT AND RELEASE, AND SETTLEMENT HEARING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><B>TO:</B></TD><TD><B>ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. (&ldquo;TACTILE&rdquo;
OR THE &ldquo;COMPANY&rdquo;) AS OF JUNE 6, 2024 (THE &ldquo;RECORD DATE&rdquo;) (&ldquo;CURRENT TACTILE STOCKHOLDERS&rdquo;).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>PLEASE READ THIS NOTICE
CAREFULLY AND IN ITS ENTIRETY. THIS <FONT STYLE="text-transform: uppercase">NOTICE RELATES TO A PROPOSED SETTLEMENT OF <I>WEAVER V. MOEN,
ET AL.</I>, CASE NO. 22-cv-01063 (the &ldquo;Action&rdquo; or &ldquo;derivative action&rdquo;), A SHAREHOLDER DERIVATIVE ACTION pending
in the united states district court for the district of delaware, AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS. IF THE COURT
APPROVES THE SETTLEMENT, YOU WILL BE FOREVER BARRED FROM CONTESTING THE APPROVAL OF THE PROPOSED SETTLEMENT AND FROM PURSUING THE &ldquo;RELEASED
CLAIMS,&rdquo; AS DEFINED IN THE STIPULATION.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
ACTION IS <U>NOT</U> A &ldquo;CLASS&nbsp;ACTION.&rdquo; THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR A MONETARY
PAYMENT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notice
is hereby provided to you of the proposed settlement (the &ldquo;Settlement&rdquo;) of this shareholder derivative lawsuit pursuant to
Federal Rule&nbsp;of Civil Procedure 23.1.<SUP>1</SUP></FONT> This Notice is provided by Order of the United States District Court for
the District of Delaware (the &ldquo;Court&rdquo;). It is not an expression of any opinion by the Court. It is to notify you of the terms
of the proposed Settlement, and your rights related thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>WHY THE COMPANY HAS ISSUED THIS NOTICE</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
June&nbsp;6, 2024, Tactile, in its capacity as a nominal defendant, as well as certain current and former officers and directors of Tactile
who were named as individual defendants,<SUP>2</SUP> entered into a Stipulation of Settlement (the &ldquo;Stipulation&rdquo;)<SUP>3</SUP>
in the Derivative Action pending before the </FONT>Court, styled <I>Weaver v. Moen, et al</I>. The Stipulation also settles the Litigation
Demand. <FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>4</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
terms of the Settlement are set forth fully in the Stipulation, which can be viewed and downloaded at </FONT><U>https://investors.tactilemedical.com/static-files/dd4bebe5-a348-4b9b-888a-c0d0e8fe8d5c</U>.
This Notice is a summary only and does not describe all of the details of the Stipulation and terms of the Settlement. For full details
of the matters discussed in this Notice, please review the Stipulation and visit <U>https://investors.tactilemedical.com/compliance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&nbsp;28, 2024, at
10:00 a.m., in Courtroom 6B of the Honorable Judge Gregory B. Williams, the Court will hold a hearing (the &ldquo;Settlement Hearing&rdquo;).
The purpose of the Settlement Hearing is to determine: (i)&nbsp;whether the terms of the Settlement are fair, reasonable, and adequate
and should be approved; (ii)&nbsp;whether a final judgment should be entered; (iii)&nbsp;whether to approve Plaintiff&rsquo;s application
for attorneys&rsquo; fees and reimbursement of expenses; and (iv)&nbsp;such other matters as may be necessary or proper under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP></FONT>A derivative lawsuit involves claims brought by a shareholder on behalf of a company, rather than on behalf of himself or
herself or the other shareholders of the company. The recovery in a derivative action is for the benefit of the company rather than directly
for individual shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP></FONT>Specifically, Brent Moen, William Burke, Peter Soderberg, Raymond O. Huggenberger, Richard Nigon, Kevin H. Roche, Lynn Blake,
Gerald R. Mattys, Robert Folkes and Bryan F. Rishe (collectively, the &ldquo;Individual Defendants&rdquo;; the Individual Defendants
together with Tactile, the &ldquo;Defendants&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3
</SUP></FONT>This Notice should be read in conjunction with, and is qualified in its entirety by reference to, the text of the Stipulation,
which has been filed with the Court (Docket No. 22-cv-01063). A link to the Form 8-K filed with the U.S. Securities and Exchange Commission
(&ldquo;SEC&rdquo;) containing the text of the Stipulation may be found on the Company's website at the Investor Relations page at <U>https://investors.tactilemedical.com/annual-reports-sec-filings</U>.
All capitalized terms herein have the same meanings as set forth in the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>4
</SUP></FONT>&ldquo;Litigation Demand&rdquo; means the demand served on Tactile and/or members of its Board of Directors on behalf of
stockholder Cory Griffin on September 2, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Summary of the Action</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>A.</B></TD><TD STYLE="text-align: justify"><B>The Now Settled Securities Class&nbsp;Actions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tactile, as well as certain
of its current and now former officers, were named as defendants in a federal securities fraud class action, entitled <I>Brian Mart,&nbsp;Individually
and on Behalf of All Others Similarly Situated v. Tactile Systems Technology,&nbsp;Inc., et al.</I>, No.&nbsp;0:20-cv-02074-NEB-BRT (D.
Minn. 2020) (the &ldquo;Securities Action&rdquo;). <FONT STYLE="background-color: white">On October&nbsp;18, 2022, the Securities Action
settled for a payment of $5 million to be distributed to buyers of Tactile stock during the Class&nbsp;Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">THIS
COURT HAS NO ROLE IN THE SECURITIES ACTION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>B.</B></FONT></TD><TD><B>Proceedings in Minnesota District Court<BR>
Preceded The Action Here Being Settled</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&nbsp;24, 2022, Plaintiff
filed a shareholder derivative complaint on behalf of Tactile in the United States District Court for the District of Minnesota, pleading
claims against the Individual Defendants, including violations of section 14(a)&nbsp;of the Securities Exchange Act, rescind compensation
under section 29(b)&nbsp;of the Securities Exchange Act, rescind employment contract compensation under section 29(b)&nbsp;of the Securities
Exchange Act, contribution under 15 U.S.C. &sect; 77 k(f)&nbsp;and 21d(5)(a)-(d)&nbsp;and for violations of sections 10(b)&nbsp;and 21d
of the Securities Exchange Act, breach of fiduciary duty, and unjust enrichment. On August&nbsp;9, 2022, the case was transferred to this
Court upon joint motion and stipulation of the parties. The claims were based on similar facts and circumstances as the Securities Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>C.</B></FONT></TD><TD><B>Proceedings in Delaware District Court</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the Action was transferred
to the Court, the litigation proceeded. On August&nbsp;25, 2022, the parties entered into a stipulation and [proposed] scheduling order
governing briefing on Defendants&rsquo; motion to stay. On September&nbsp;27, 2022, Defendants filed their motion and brief in support
of their motion to stay. On November&nbsp;14, 2022, Plaintiff filed his brief in opposition to Defendants&rsquo; motion to stay. On November&nbsp;30,
2022, Defendants filed their notice to withdraw motion to stay. On January&nbsp;31, 2023, the parties filed their stipulation for a briefing
schedule on Defendants&rsquo; motion to dismiss. On February&nbsp;10, 2023, Defendants filed their motion to dismiss for failure to state
a claim. On March&nbsp;6, 2023, Plaintiff filed his amended complaint in this Court pleading claims against the Individual Defendants,
including violations of section 14(a)&nbsp;of the Securities Exchange Act, rescind compensation under section 29(b)&nbsp;of the Securities
Exchange Act, rescind employment contract compensation under section 29(b)&nbsp;of the Securities Exchange Act, contribution under 15
U.S.C. &sect; 77 k(f)&nbsp;and 21d(5)(a)-(d)&nbsp;and for violations of sections 10(b)&nbsp;and 21d of the Securities Exchange Act, breach
of fiduciary duty, and unjust enrichment. On March&nbsp;31, 2023, Defendants filed their motion to dismiss the amended complaint. On April&nbsp;14,
2023, the parties filed their first joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss. On May&nbsp;3,
2023, the parties filed their second joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss. On June&nbsp;5,
2023, the parties filed their third joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>D.</B></TD><TD><B>The Extensive Settlement Negotiations</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Plaintiff&rsquo;s Counsel
engaged in extensive and ongoing settlement negotiations with the Defendants&rsquo; Counsel over the course of several months. On November&nbsp;11,
2022, Plaintiff made an initial settlement demand. On December&nbsp;26, 2022, Plaintiff agreed to invite the mediator who mediated the
Securities Action settlement to review their settlement demand. Over the next several months, the Settling Parties<SUP>5</SUP> exchanged
proposals and counter proposals and participated in multiple conference calls. These extensive negotiations resulted in the execution
on October&nbsp;26, 2023 of a settlement term sheet that memorialized the material terms of the settlement (&ldquo;Term Sheet&rdquo;).
The Settling Parties have expended significant time and resources participating in settlement communications in which the merits of the
claims asserted in the Derivative Action, as well as the defenses thereto, were extensively discussed between the Settling Parties. The
Settling Parties have now reached a definitive agreement to settle the Derivative Action, upon the terms and subject to the conditions
set forth in the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>SETTLEMENT</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&nbsp;6, 2024, the
Plaintiff,<SUP>&#8239;6</SUP> Demand Shareholder,<SUP>7</SUP> and Defendants entered into the Stipulation to resolve the Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Stipulation,
the Defendants shall cause Tactile to adopt, implement and maintain the corporate guidance provisions described in Exhibit&nbsp;A to the
Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tactile</FONT>
and its Board acknowledged and agreed that Plaintiff&rsquo;s efforts, including his efforts in investigating, preparing, commencing, and
prosecuting the Derivative Action, was a material cause for the implementation of these reforms, and that the reforms confer substantial
benefits upon Tactile and its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Stipulation also provides
for the entry of judgment dismissing the Action against the Defendants with prejudice and, as explained fully in the Stipulation, releasing
and discharging certain known and unknown claims that could have been brought in any court, whether arising under federal, state, common,
or foreign law, which exist derivatively on behalf of Tactile, by Plaintiff or any other shareholder of Tactile that arise out of or relate
in any way to the claims asserted or that could have been asserted in any of the complaints in the Action, or the Litigation Demand, or
that arise out of, or relate in any way to the institution, prosecution, or settlement of the claims against the Defendants by Plaintiff
in the Action or Litigation Demand against Defendants, Tactile, and Tactile&rsquo;s past, present, and future officers and/or directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>5
</SUP></FONT>As set forth in the Stipulation, &ldquo;Settling Parties&rdquo; refers to Plaintiff, Demand Shareholder, and Defendants,
collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>6
</SUP></FONT>As set forth in the Stipulation, &ldquo;Plaintiff&rdquo; refers to Jack Weaver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>7
</SUP></FONT>As set forth in the Stipulation, &ldquo;Demand Shareholder&rdquo; refers to Cory Griffin.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Plaintiff&rsquo;s Attorneys&rsquo; Fees and Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After negotiating the financial
recovery and the corporate guidance provisions, the Settling Parties began negotiating the attorneys&rsquo; fees that Tactile or Defendants&rsquo;
insurance carrier(s)&nbsp;would pay to Plaintiff&rsquo;s Counsel and Demand Shareholder&rsquo;s Counsel. In light of the substantial benefits
secured for Tactile by Plaintiff, Demand Shareholder, and their respective counsel in connection with the Settlement and the litigation
leading up to it, the Settling Parties have agreed that Plaintiff will seek an award of attorneys fees and expenses and service awards
for Plaintiff and Demand Shareholder not to exceed $485,000, all inclusive. Tactile has agreed that it or its insurers will pay any award
up to $485,000 but will not pay in connection with any request for fees from Plaintiff&rsquo;s counsel or Litigation Demand counsel which
exceeds $485,000. All of the foregoing is subject to Court approval. <FONT STYLE="background-color: white">Plaintiff&rsquo;s Counsel will
request Court approval for the payment to Plaintiff and Demand Shareholder of service awards in an amount not to exceed $7,500, subject
to Court approval, which will be funded from the Fee and Expense Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase; background-color: white"><B>Reasons for the Settlement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">The
Court did not decide in favor of the Plaintiff or the Defendants. The proposed Settlement was negotiated at arm&rsquo;s-length by attorneys
representing the Settling Parties. The attorneys for all of the Settling Parties have extensive experience in shareholder derivative cases,
and they all believe the Settlement is in the best interest of their clients. Tactile and Plaintiff believes that the Settlement provides
substantial benefits upon Tactile and its shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="background-color: white"><B>5.1</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>Why Did the Plaintiff Agree to Settle?</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Plaintiff&rsquo;s
Counsel investigated claims and the underlying events and transactions alleged in the Action. Plaintiff&rsquo;s Counsel have analyzed
the evidence adduced during their investigation and have researched the applicable law with respect to the claims of Plaintiff, Tactile,
and its shareholders against the Defendants and the potential defenses thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Based
upon their investigation, Plaintiff and Plaintiff&rsquo;s Counsel have concluded that the terms and conditions of the Settlement are fair,
reasonable, and adequate to Plaintiff, current shareholders of Tactile, and Tactile, and in their best interests, and have agreed to settle
the claims raised in the Action pursuant to the terms and provisions of the Stipulation after considering, among other things: (a)&nbsp;the
substantial benefits that Tactile and its shareholders will receive from the Settlement; (b)&nbsp;the attendant risks of continued litigation
of the Action; and (c)&nbsp;the desirability of permitting the Settlement to be consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">In
particular, Plaintiff and Plaintiff&rsquo;s Counsel considered the significant litigation risk inherent in this Action. The law imposes
significant burdens on Plaintiff for pleading and proving a shareholder derivative claim. While Plaintiff believes his claims are meritorious,
Plaintiff acknowledges that there is a substantial risk that the Action may not succeed in producing a recovery in light of the applicable
legal standards and possible defenses. Plaintiff and Plaintiff&rsquo;s Counsel believe that, under the circumstances, they have obtained
the best possible relief for Tactile and its shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="background-color: white"><B>5.2</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white"><B>Why Did the Defendants Agree to Settle?</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Individual Defendants have denied and continue to deny each and all of the claims and allegations alleged by Plaintiff in the Derivative
Action and Litigation Demand, and the Individual Defendants have expressly denied and continue to deny all charges of wrongdoing or liability
against them arising out of any of the conduct, statements, acts, or omissions alleged, or that could have been alleged in the Derivative
Action and Litigation Demand. The Individual Defendants believe that they have substantial defenses to the claims and allegations alleged
against them in the Derivative Action and Litigation Demand. The Individual Defendants believe that, at all relevant times, they acted
in good faith, and in a manner they reasonably believed to be in the best interests of Tactile and its stockholders. Nonetheless, the
Individual Defendants have also taken into account the uncertainty and risks inherent in any litigation, especially in complex cases like
the Derivative Action. The Individual Defendants have, therefore, determined that it is in the best interests of Tactile for the Derivative
Action and Litigation Demand to be settled in the manner and upon the terms and conditions set forth in this Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>6.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase; background-color: white"><B>Settlement Hearing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
August&nbsp;28, 2024, at 10:00 a.m., in Courtroom 6B of the Honorable Judge Gregory B. Williams, the Court will hold the Settlement Hearing.
At the Settlement Hearing, the Court will consider whether the terms of the Settlement are fair, reasonable, and adequate and thus should
be finally approved, and whether the Action should be dismissed with prejudice pursuant to the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>7.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Right to Attend Settlement Hearing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any
Current Tactile Shareholder may, but is not required to, appear in person at the Settlement Hearing. If you want to be heard at the Settlement
Hearing, then you must first comply with the procedures for objecting, which are set forth below. The Court has the right to change the
hearing dates or times without further notice. Thus, if you are planning to attend the Settlement Hearing, you should confirm the date
and time before going to the Court. CURRENT TACTILE SHAREHOLDERS WHO HAVE NO OBJECTION TO THE SETTLEMENT DO NOT NEED TO APPEAR AT THE
SETTLEMENT HEARING OR TAKE ANY OTHER ACTION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>8.</B></FONT></TD><TD><FONT STYLE="text-transform: uppercase"><B>Right to Object to Settlement and Procedures for Doing So</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
have the right to object to any aspect of the Settlement. You must object in writing, and you may request to be heard at the Settlement
Hearing. If you choose to object, then you must follow these procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>8.1</B></TD><TD><B>You Must Make Detailed Objections in Writing</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any
objection must be presented in writing and must contain the following information. The Court may not consider any objection that does
not substantially include the following information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">1)</TD><TD STYLE="text-align: justify">Your name, legal address, and telephone number;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">2)</TD><TD STYLE="text-align: justify">The case name and number (<I>Weaver v. Moen, et al.</I>, Case No.&nbsp;22-cv-01063);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">3)</TD><TD STYLE="text-align: justify">Proof of being a current Tactile stockholder as of the Record Date, June&nbsp;6, 2024;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">4)</TD><TD STYLE="text-align: justify">The date(s)&nbsp;you acquired your Tactile shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">5)</TD><TD STYLE="text-align: justify">A statement of your position regarding the matters to be heard at the Settlement Hearing, including the
grounds for each objection or the reasons you desire to appear and be heard;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">6)</TD><TD STYLE="text-align: justify">Notice of whether you intend to appear at the Settlement Hearing (though attendance is not required if
you have lodged your objection);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">7)</TD><TD STYLE="text-align: justify">Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intent
to call to testify at the Settlement Hearing and the subject(s)&nbsp;of any expected testimony;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">8)</TD><TD STYLE="text-align: justify">The identities of any cases, by name, court, and docket number, in which the objector or his, her, or
its attorney has objected to a settlement in the last three years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>8.2</B></TD><TD><B>You Must Timely Deliver Written Objections to the Court, Plaintiff&rsquo;s Counsel, and Defendants&rsquo; Counsel</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">YOUR
WRITTEN OBJECTIONS MUST BE ON FILE WITH THE CLERK OF THE COURT NO LATER THAN 20 CALENDAR DAYS BEFORE THE SETTLEMENT HEARING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Court Clerk's Address is: United States District Court, District of Delaware, 844 North King Street, Unit 18, Wilmington, Delaware 19801-3570.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">YOU
ALSO MUST DELIVER COPIES OF THE MATERIALS TO COUNSEL FOR PLAINTIFF AND COUNSEL FOR DEFENDANTS SO THEY ARE RECEIVED NO LATER THAN 20 CALENDAR
DAYS BEFORE THE SETTLEMENT HEARING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Counsel for Plaintiff:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Lee Squitieri&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><B>SQUITIERI&nbsp;&amp; FEARON, LLP&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">305 Broadway&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">7th Floor&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, New York 10007&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">(212) 421-6492</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Counsel for Defendants:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Joseph C. Schoell (#3133)<BR>
<B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH LLP&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">222 Delaware Avenue,
Suite&nbsp;1410&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Wilmington, Delaware
19801&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(302) 467-4200&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">joseph.schoell@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Matthew Kilby (<I>pro hac vice</I>)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Rory F. Collins (<I>pro hac vice</I>)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">Anderson Tuggle (<I>pro hac vice</I>)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH
LLP&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">2200 Wells Fargo Center<BR>
99 South Seventh Street<BR>
Minneapolis, MN 55402&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">(612) 766-7000&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">matthew.kilby@faegredrinker.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">rory.collins@faegredrinker.com<BR>
anderson.tuggle@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>How to Obtain More Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Notice summarizes the
Settlement. It is not a complete statement of the events of the Action, the Settlement, or the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
may inspect the Stipulation and other papers in the Action at the Clerk of the Court, 844 North King Street, Unit 18, Wilmington, Delaware
19801-3570, at any time during regular business hours of each business day. You may also visit </FONT><FONT STYLE="text-decoration: underline">https://investors.tactilemedical.com/compliance</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">PLEASE
DO NOT CALL, WRITE, OR OTHERWISE DIRECT QUESTIONS TO EITHER THE COURT OR THE CLERK&rsquo;S OFFICE. Any questions you have about matters
in this Notice should be directed by telephone to Lee Squitieri (</FONT><FONT STYLE="text-decoration: underline">lee@sfclasslaw.com</FONT>) at (212)
421-6492 or in writing to Squitieri&nbsp;&amp; Fearon, LLP, 305 Broadway, 7th Floor, New York, New York 10007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED:</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">July&nbsp;5,
2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BY ORDER OF THE COURT UNITED STATES DISTRICT COURT
DISTRICT OF DELAWARE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>tm2418929d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES DISTRICT COURT&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DISTRICT
OF </B></FONT><B>DELAWARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>JACK WEAVER, Derivatively on
    Behalf of TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Plaintiff,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">v.</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BRENT MOEN, et al.,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Defendants,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">-and-</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Nominal Defendant.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P></TD>
    <TD STYLE="text-align: left; width: 65%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASE
NO. </FONT>1:22-cv-01063-GBW</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>STIPULATION OF SETTLEMENT</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Stipulation of Settlement,
dated June&nbsp;6, 2024 (the &ldquo;Stipulation&rdquo;), is made and entered into by and among the following Settling Parties, by and
through their respective counsel of record: (i)&nbsp;plaintiff Jack Weaver (&ldquo;Plaintiff&rdquo;), individually and derivatively on
behalf of nominal defendant Tactile Systems Technology,&nbsp;Inc. (&ldquo;Tactile&rdquo; or the &ldquo;Company&rdquo;); (ii)&nbsp;Cory
Griffin (the &ldquo;Demand Shareholder&rdquo;)<SUP>1</SUP>; (iii)&nbsp;defendants Brent Moen, William Burke, Peter Soderberg, Raymond
Huggenberger, Richard Nigon, Kevin Roche, Lynn Blake, Gerald Mattys, Robert Folkes and Bryan Rishe (collectively, the &ldquo;Individual
Defendants&rdquo;); and (iv)&nbsp;nominal defendant Tactile (collectively the &ldquo;Settling Parties&rdquo;). This Stipulation is intended
by the Settling Parties<SUP>2</SUP> to fully, finally, and forever resolve, discharge, and settle the Released Claims, subject to the
terms and conditions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><SUP>1</SUP> Together, Plaintiff
and the Demand Shareholder are referred to herein as the &ldquo;Shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><SUP>2</SUP> All capitalized
terms not otherwise defined are defined in section IV.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>I.</B></FONT></TD><TD STYLE="text-align: justify"><B>FACTUAL AND PROCEDURAL BACKGROUND</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Pre-Suit
Investigative Activity: Investigative Demand For Books And Records Pursuant To Delaware Counsel&nbsp;Corporate Law Section&nbsp;220</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
November&nbsp;2020, Plaintiff, through his counsel, served a demand to inspect books and records (the &ldquo;Weaver 220 Demand&rdquo;)
pursuant to 8 Del. C. &sect; 220 (&ldquo;Section&nbsp;220&rdquo;). Plaintiff served additional demands under Section&nbsp;220 on </FONT>December&nbsp;3,
2020, December&nbsp;21, 2020, and June&nbsp;4, 2021 and negotiated with Tactile&rsquo;s counsel regarding the scope of production, terms
of confidentiality and other matters from November&nbsp;2020 to August&nbsp;2021. After signing a Confidentiality Agreement, Tactile made
a production of 1,953 pages&nbsp;of Tactile internal confidential documents to Plaintiff bate stamped TAC_WEAVER_000001 <B>- </B>TAC_WEAVER_001953.
Plaintiff&rsquo;s counsel thereupon reviewed and analyzed the documents to prepare a shareholder derivative complaint against the Individual
Defendants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>B.</B></TD><TD STYLE="text-align: justify"><B>Proceedings in the Related Federal Securities Action</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
mid-2020 Tactile, as well as certain of its current and now former officers, were named as defendants in a federal securities fraud class
action, entitled <I>Brian Mart,&nbsp;Individually and on Behalf of All Others Similarly Situated v. Tactile Systems Technology,&nbsp;Inc.,
et al.</I>, No.&nbsp;0:20-cv-02074-NEB-BRT (D. Minn. 2020) (the &ldquo;Securities Action&rdquo;). The plaintiff in the Securities Action
alleged that the defendants engaged in fraudulent schemes and misconduct, and/or made materially false and misleading statements and/or
failed to disclose that: (i)&nbsp;to induce sales growth of Tactile&rsquo;s flagship product, Flexitouch</FONT>, Tactile and/or its employees
engaged in illicit sales and marketing activities involving kickback schemes and the submission of false claims to federal healthcare
programs in violation of applicable federal statutes; (ii)&nbsp;Tactile&rsquo;s revenues were in part the product of unlawful conduct
and were thus unsustainable; (iii)&nbsp;while Tactile publicly touted a $4 plus or $5 plus billion market opportunity for its advanced
PCDs, in truth, the total addressable market was at least three times smaller; and (iv)&nbsp;Tactile overstated its revenue from the Department
of Veterans Affairs and the Center for Medicare&nbsp;&amp; Medicaid Services. The plaintiff in the Securities Action alleged that, as
a consequence of the defendants&rsquo; allegedly false and misleading public statements, Tactile securities traded at artificially inflated
prices during the Class&nbsp;Period until the alleged wrongdoing was disclosed, and the prices of Tactile securities fell, causing damages
to stock buyers. On March&nbsp;31, 2022, the court granted in part and denied in part the motion to dismiss filed in the Securities Action,
<I>Mart v. Tactile Sys. Tech.,&nbsp;Inc.</I>, 595 F. Supp. 3d 788, 799 (D. Minn. 2022), and the case proceeded to discovery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October&nbsp;18, 2022 the
Securities Action settled for a payment of $5 million to be distributed to buyers of Tactile stock during the Class&nbsp;Period, funded
by Tactile&rsquo;s insurers. On August&nbsp;25, 2023, the court granted final approval to the settlement and plan of allocation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At all times, defendants in
the Securities Action contended that they did not engage in any fraudulent schemes, acts, or misconduct, and that the sales, marketing,
and educational activities described in the Securities Action complaint were compliant with applicable law. Defendants further contended
that they did not make any materially false or misleading statements, that they disclosed all material information required to be disclosed
by the federal securities laws, and that any alleged misstatements or omissions were not made with the requisite intent or knowledge of
wrongdoing. Defendants also contend that any losses allegedly suffered by Members of the Class&nbsp;were not caused by any allegedly false
or misleading statements by them, or allegedly fraudulent schemes, acts, or misconduct by them, and/or were caused by intervening events.
Defendants believed that the claims asserted against them in the Securities Action were without merit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>C.</B></TD><TD STYLE="text-align: justify"><B>Section&nbsp;220 Investigation and Litigation Demand by the Demand Shareholder</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&nbsp;10, 2022,
the Demand Shareholder issued a demand to inspect certain internal books and records of Tactile pursuant to Section&nbsp;220 (the &ldquo;Griffin
220 Demand&rdquo;). Following meet and confer negotiations, Tactile produced approximately 1,821 pages&nbsp;of confidential, Board-level
materials to the Demand Shareholder and Demand Shareholder&rsquo;s Counsel. Thereafter, Demand Shareholder&rsquo;s Counsel reviewed and
analyzed these materials and concluded that pre-suit demand on Tactile&rsquo;s Board was required, due to material changes in the makeup
of Tactile&rsquo;s Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By letter dated September&nbsp;2,
2022, the Demand Shareholder issued a litigation demand to Tactile&rsquo;s Board pursuant to Delaware law, which demanded, <I>inter alia</I>,
that the Board commence an independent investigation into whether certain current and former directors and officers: (i)&nbsp; failed
to ensure that the Company&rsquo;s remuneration plans were compliant with federal and state law (<I>i.e.,</I> were not based on the payment
of illegal kick-backs); and (ii)&nbsp;whether these individuals caused the Company to issue a series of materially false and misleading
statements concerning Flexitouch (the &ldquo;Litigation Demand&rdquo;). The Litigation Demand purported to rely on documents produced
by Tactile in response to the Griffin 220 Demand. Demand Shareholder&rsquo;s Counsel was informed by email on September&nbsp;9, 2022,
that the Litigation Demand had been forwarded to Tactile&rsquo;s Board for consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>This
Action Was First Filed in Minnesota District Court</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&nbsp;24, 2022, Plaintiff
filed a shareholder derivative complaint on behalf of Tactile in the United States District Court for the District of Minnesota (the
 &ldquo;Derivative Action&rdquo;), pleading claims against the Individual Defendants, including for violations of section 14(a)&nbsp;of
the Securities Exchange Act, to rescind compensation under section 29(b)&nbsp;of the Securities Exchange Act, to rescind employment contract
compensation under section 29(b)&nbsp;of the Securities Exchange Act, for contribution under 15 U.S.C. &sect; 77 k(f)&nbsp;and 21d(5)(a)-(d)&nbsp;and
for violations of sections 10(b)&nbsp;and 21(d)&nbsp;of the Securities Exchange Act, breach of fiduciary duty, and unjust enrichment.
The claims alleged that derelictions of duties by the Individual Defendants had allowed Tactile to engage in activities that gave rise
to several lawsuits which Tactile had to expend time and money to defend and/or settle. On August&nbsp;9, 2022, the case was transferred
to this Court upon joint motion and stipulation of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Proceedings
in Delaware District Court</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the action was transferred
to this Court, on August&nbsp;25, 2022, the parties entered into a stipulation and proposed scheduling order governing briefing on Defendants&rsquo;
motion to stay. On September&nbsp;27, 2022, Defendants filed their motion and brief in support of their motion to stay. On November&nbsp;14,
2022, Plaintiff filed his brief in opposition to Defendants&rsquo; motion to stay. On November&nbsp;30, 2022, Defendants filed their notice
to withdraw the motion to stay in light of resolution of the Securities Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&nbsp;31, 2023,
the parties filed their stipulation for a briefing schedule on Defendants&rsquo; motion to dismiss. On February&nbsp;10, 2023, Defendants
filed their motion to dismiss for failure to state a claim. In response, on March&nbsp;6, 2023, Plaintiff filed his amended complaint
in this Court pleading claims against the Individual Defendants, including violations of section 14(a)&nbsp;of the Securities Exchange
Act, and to rescind compensation under section 29(b)&nbsp;of the Securities Exchange Act, and to rescind employment contract compensation
under section 29(b)&nbsp;of the Securities Exchange Act, and for contribution under 15 U.S.C. &sect; 77 k(f)&nbsp;and 21d(5)(a)-(d)&nbsp;and
for violations of sections 10(b)&nbsp;and 21(d)&nbsp;of the Securities Exchange Act, breach of fiduciary duty, and unjust enrichment.
On March&nbsp;31, 2023, Defendants filed their motion to dismiss the amended complaint. On April&nbsp;14, 2023, the parties filed their
first joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss. On May&nbsp;3, 2023, the parties filed
their second joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss. On June&nbsp;5, 2023, the parties
filed their third joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>F.</B></TD><TD STYLE="text-align: justify"><B>The Extensive Settlement Negotiations</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
November&nbsp;11, 2022, Plaintiff made his first settlement demand on Defendants.</FONT> In November&nbsp;2022, Demand Shareholder&rsquo;s
Counsel spoke with Defendants&rsquo; counsel regarding a potential settlement of the Demand Shareholder&rsquo;s claims. Demand Stockholder&rsquo;s
Counsel sent a settlement demand to Defendants dated December&nbsp;13, 2022. Settlement discussions continued over the course of several
months and culminated in a comprehensive settlement term sheet on or about October&nbsp;26, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Settling Parties have
expended significant time and resources participating in conference calls and meetings during which the merits of the claims asserted
by the Shareholders, as well as the defenses thereto, were extensively discussed between the Settling Parties. The Settling Parties have
now reached a definitive agreement to settle the Derivative Action and claims raised in the Litigation Demand, upon the terms and subject
to the conditions set forth in this Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>II.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>PLAINTIFF&rsquo;s CLAIMS AND THE BENEFITS OF SETTLEMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Plaintiff believes that the
Derivative Action has substantial merit, and Plaintiff&rsquo;s entry into this Stipulation and Settlement is not intended to be and shall
not be construed as an admission or concession concerning the relative strength or merit of the claims alleged in the Derivative Action.
However, Plaintiff and Plaintiff&rsquo;s Counsel recognize and acknowledge the significant risk, expense, and length of continued proceedings
necessary to prosecute the Derivative Action against the Individual Defendants through trial and possible appeals. Plaintiff&rsquo;s Counsel
are also mindful of the inherent risks of succeeding on the merits in derivative litigation, and the possible defenses to the claims alleged
in the Derivative Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Plaintiff&rsquo;s Counsel
have conducted an extensive factual investigation into Tactile&rsquo;s non-public Board-level documents via the inspection process pursuant
to Section&nbsp;220. Plaintiff&rsquo;s Counsel have also performed additional investigation, including, <I>inter alia</I>: (i)&nbsp;reviewing
Tactile's press releases, public statements, U.S. Securities and Exchange Commission filings, and securities analysts&rsquo; reports and
advisories about the Company; (ii)&nbsp;reviewing related media reports about the Company; (iii)&nbsp;researching applicable law with
respect to the claims alleged in the Derivative Action and potential defenses thereto; (iv)&nbsp;preparing and filing initial and amended
derivative complaints; (v)&nbsp;briefing motions to stay; (vi)&nbsp;conducting damages analyses; (vii)&nbsp;reviewing and analyzing relevant
documents filed in the Securities Action and evaluating the merits of, and potential liability in connection with, the Securities Action;
(viii)&nbsp;analyzing areas of improvement to Tactile&rsquo;s corporate governance; and (ix)&nbsp;negotiating this Settlement with Defendants,
including researching corporate governance best practices and negotiating the Reforms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on Plaintiff&rsquo;s
Counsel&rsquo;s thorough review and analysis of the relevant facts, allegations, defenses, and controlling legal principles, Plaintiff&rsquo;s
Counsel believe that the Settlement set forth in this Stipulation is fair, reasonable, and adequate, and confers substantial benefits
upon Tactile. Based upon Plaintiff&rsquo;s Counsel&rsquo;s evaluation, Plaintiff has determined that the Settlement is in the best interests
of Tactile and has agreed to settle the Derivative Action upon the terms and subject to the conditions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>III.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Defendants&rsquo; DENIALS OF WRONGDOING AND LIABILITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Individual Defendants
have denied and continue to deny each and all of the claims alleged by Plaintiff in the Derivative Action, and the Individual Defendants
have expressly denied and continue to deny all charges of wrongdoing or liability against them arising out of any of the conduct, statements,
acts, or omissions alleged, or that could have been alleged in the Derivative Action. The Individual Defendants believe that they have
complete defenses to the claims alleged against them in the Derivative Action. The Individual Defendants believe that, at all relevant
times, they acted in good faith, and in a manner they reasonably believed to be in the best interests of Tactile and its stockholders.
Nonetheless, Defendants have also taken into account the uncertainty and risks inherent in any litigation, including in complex cases
like the Derivative Action. Defendants have, therefore, determined to settle the Derivative Action in the manner and upon the terms and
conditions set forth in this Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither this Stipulation,
nor any of its terms or provisions, nor entry of the Judgment, nor any document or exhibit referred or attached to this Stipulation, nor
any action taken to carry out this Stipulation, is, may be construed as, or may be used as evidence of the validity of any of the Released
Claims or an admission by or against the Individual Defendants of any fault, wrongdoing, or concession of liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase"><B>IV.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;IT IS
HEREBY STIPULATED AND AGREED by and among the undersigned counsel for the Settling Parties herein, in consideration of the benefits flowing
to the Settling Parties from the Settlement, and subject to the approval of the Court, that the claims asserted in the Derivative Action
and the Released Claims shall be finally and fully compromised, settled, and released, and the Derivative Action and Litigation Demand
shall be dismissed with prejudice and with full preclusive effect as to all Settling Parties upon and subject to the terms and conditions
of this Stipulation, as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Definitions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this Stipulation,
the following terms have the meanings specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">&ldquo;Court&rdquo; means the United States District Court for the District of Delaware.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Current
Tactile Shareholders&rdquo; means any Person who owned Tactile common stock as of the date of the execution of this Stipulation and continues
to hold their Tactile common stock as of the date of the Settlement Hearing, excluding the Individual Defendants, the officers and directors
of Tactile, members of their immediate families, and their legal representatives, heirs, successors, or assigns, and any entity in which
Individual Defendants have or had a controlling interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Demand
Shareholder&rdquo; means Tactile stockholder Cory Griffin.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Demand
Shareholder&rsquo;s Counsel&rdquo; means Shuman, Glenn&nbsp;&amp; Stecker.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Defendants&rdquo;
means, collectively, nominal defendant Tactile and the Individual Defendants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Defendants&rsquo;
Counsel&rdquo; means Faegre Drinker Biddle&nbsp;&amp; Reath LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Derivative
Action&rdquo; means this civil action, as captioned on the first page&nbsp;of this Stipulation of Settlement..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Effective
Date&rdquo; means the date by which the events and conditions specified in paragraph 6.1 of this Stipulation have been met and have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Final&rdquo;
means the date upon which the last of the following shall occur with respect to the Judgment approving this Stipulation, substantially
in the form of Exhibit&nbsp;B attached hereto: (1)&nbsp;the expiration of the time to file a notice of appeal from the Judgment; or (2)&nbsp;if
an appeal has been filed, the Third Circuit has either affirmed the Judgment or dismissed that appeal and the time for any reconsideration
or further appellate review has passed; or (3)&nbsp;if a higher court has granted further appellate review, that court has either affirmed
the underlying Judgment or affirmed the Third Circuit&rsquo;s decision affirming the Judgment or dismissing the appeal. For purposes of
this paragraph, an &ldquo;appeal&rdquo; shall not include any appeal that concerns only the issue of attorneys&rsquo; fees and expenses
or the payment of a service award. Any proceeding or order, or any appeal or petition for a writ of certiorari pertaining solely to the
application for attorneys&rsquo; fees, costs, or expenses, shall not in any way delay or preclude the Judgment from becoming Final.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Individual
Defendants&rdquo; means Defendants Brent Moen, William Burke, Peter Soderberg, Raymond Huggenberger, Richard Nigon, Kevin Roche, Lynn
Blake, Gerald Mattys, Robert Folkes and Bryan Rishe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Judgment&rdquo;
means the Order and Final Judgment to be rendered by the Court, substantially in the form attached hereto as Exhibit&nbsp;B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Litigation
Demand&rdquo; means, the demand served on Tactile and/or members of its Board of Directors on behalf of Tactile shareholder Cory Griffin.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Mediator&rdquo;
means Michelle Yoshida of Phillips ADR,&nbsp;Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Notice&rdquo;
means the Notice of Pendency and Proposed Settlement of Shareholder Derivative Action and of Settlement Hearing, substantially in the
form attached hereto as Exhibit&nbsp;C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Person&rdquo;
means an individual, corporation, limited liability corporation, professional corporation, partnership, limited partnership, limited liability
partnership, association, joint stock company, estate, legal representative, trust, unincorporated association, government or any political
subdivision or agency thereof and any business or legal entity and their spouses, heirs, predecessors, successors, representatives, or
assignees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Plaintiff&rdquo;
means Jack Weaver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Plaintiff&rsquo;s
Counsel&rdquo; means Squitieri&nbsp;&amp; Fearon, LLP, Moore Kuehn, PLLC and Rigrodsky Law, P.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Related
Persons&rdquo; means: (i)&nbsp;a Person&rsquo;s spouses, marital communities, immediate family members, heirs, executors, personal representatives,
estates, administrators, trusts, predecessors, successors, and assigns or other individual or entity in which any Person has a controlling
interest, and each of their respective past and present officers, directors, employees, agents, affiliates, parents, subsidiaries, divisions,
attorneys, accountants, auditors, advisors, insurers, co-insurers, re-insurers, heirs, executors, personal representatives, estates, administrators,
trusts, predecessors, successors, and assigns; and (ii)&nbsp;with regard to Tactile, all past or present agents, officers, directors,
attorneys, accountants, auditors, advisors, insurers, co-insurers, reinsurers, partners, controlling shareholders, joint venturers, related
or affiliated entities, advisors, employees, affiliates, predecessors, successors, parents, subsidiaries, insurers, and assigns for Tactile.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Released
Claims&rdquo; means collectively, the Released Defendant Claims and the Released Plaintiff Claims.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Released
Defendant Claims&rdquo; means any and all actions, suits, claims, debts, rights, liabilities, and causes of action of every nature and
description, including both known and Unknown Claims (as defined in paragraph 1.31 below), whether arising under federal, state, common,
or foreign law, that arise out of or relate in any way to the claims asserted in the complaints in the Derivative Action and/or the Litigation
Demand or arise out of, or relate in any way to the institution, prosecution, or settlement of the claims against the Defendants, except
for (i)&nbsp;any claims relating to the enforcement of the Settlement, or (ii)&nbsp;any claims by the Individual Defendants relating to
insurance coverage or their right to indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Released
Defendant Persons&rdquo; means, collectively, each and all of Individual Defendants, Tactile, and each and all of the Related Persons
of each of the Individual Defendants and Tactile.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Released
Persons&rdquo; means, collectively, the Released Defendant Persons and the Released Plaintiff Persons. &ldquo;Released Person&rdquo; means,
individually, any of the Released Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Released
Plaintiff Claims&rdquo; means any and all actions, suits, claims, debts, rights, liabilities, and causes of action of every nature and
description, including both known and Unknown Claims (as defined in paragraph 1.31 below), whether arising under federal, state, common,
or foreign law, which exist derivatively on behalf of Tactile, by Plaintiff, Demand Shareholder or any other shareholder of Tactile that
arise out of or relate in any way to the claims asserted or that could have been asserted, or the allegations made, in any of the complaints
in the Derivative Action or the Litigation Demand, or that arise out of, or relate in any way to the institution, prosecution, or settlement
of the claims against the Defendants, except for any claims relating to enforcing the Settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Released
Plaintiff Persons&rdquo; means the Plaintiff and Demand Shareholder and each and all of the Related Persons of Plaintiff and Demand Shareholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Securities
Action&rdquo; means the securities class action styled as <I>Mart v. Tactile Systems Technology,&nbsp;Inc., et al.</I>, 20-2074 (U.S.D.C.
D.Minn.).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Settlement&rdquo;
means the settlement and compromise of the Derivative Action as provided for herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.27</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Settlement
Hearing&rdquo; means the hearing or hearings at which the Court will review the adequacy, fairness, and reasonableness of the Settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.28</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Settling
Parties&rdquo; means, collectively, Plaintiff, Demand Shareholder and Defendants. &ldquo;Settling Party&rdquo; means, individually, any
of the Settling Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.29</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Shareholders&rdquo;
means, collectively, Plaintiff and Demand Shareholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Summary
Notice&rdquo; means the Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Action and of Settlement Hearing,
substantially in the form attached hereto as Exhibit&nbsp;D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.31</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt">&ldquo;Unknown
Claims&rdquo; means any Released Claim(s)&nbsp;that any of Plaintiff, the Demand Shareholder, or any Defendant does not know of or suspect
to exist in his, her, or its favor at the time of the release of the Released Persons. With respect to any and all Released Claims, the
Settling Parties agree that upon the Effective Date, the Settling Parties expressly waive the provisions, rights and benefits conferred
by or under California Civil Code section 1542, or any other law of the United States or any state or territory of the United States,
or principle of common law, which is similar, comparable, or equivalent to section 1542, which provides:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="text-transform: uppercase">A
general release does not extend to claims which the creditor or releasing party does not know or suspect to exist in his or her favor
at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor
or released party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Settling Parties acknowledge that they may
hereafter discover facts in addition to or different from those now known or believed to be true by them, with respect to the subject
matter of the Released Claims, but it is the intention of the Settling Parties to completely, fully, finally, and forever compromise,
settle, release, discharge, and extinguish any and all Released Claims, known or unknown, suspect or unsuspected, contingent or absolute,
accrued or unaccrued, apparent or unapparent, which do now exist, or heretofore existed, or may hereafter exist, and without regard to
the subsequent discovery of additional or different facts. The Settling Parties acknowledge that the foregoing waiver was separately bargained
for and is a key element of this Stipulation of which this release is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.32</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Tactile&rdquo;
or the &ldquo;Company&rdquo; means nominal defendant Tactile, a Delaware corporation, and its affiliates, subsidiaries, predecessors,
successors, and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Terms of the Settlement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Corporate
Governance Reforms</U>. Tactile shall, within sixty (60) days of final approval of the Settlement, adopt the corporate governance reforms
identified in Exhibit&nbsp;A attached hereto (&ldquo;Reforms&rdquo;) and maintain the Reforms for a period of no less than three (3)<B>&nbsp;</B>years
from the date that they are adopted, unless any Reform (or part of any Reform) is rendered unlawful or ill-advised under any statute or
regulation. The Board may exercise its discretion in deciding whether to continue any of the Reforms after the third anniversary of their
implementation. The Board shall take steps necessary to authorize adequate funding for the costs of implementing and maintaining the Reforms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Tactile&rsquo;s
Board has unanimously approved a resolution reflecting their determination, in a good faith exercise of business judgment, that: (i)&nbsp;
the Derivative Action and the Litigation Demand and settlement efforts in connection with the Derivative Action and Litigation Demand
were a material cause of the Board&rsquo;s decision to adopt, implement, and maintain the Reforms, and that certain of the Reforms would
not have been adopted, implemented, or maintained but for Plaintiff&rsquo;s and Demand Shareholder&rsquo;s efforts; (b)&nbsp;the Reforms
confer substantial and material corporate benefits on the Company and its stockholders; and (c)&nbsp;the Settlement is fair, reasonable,
and in the best interests of Tactile and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Approval and Notice</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Promptly
after execution of this Stipulation, the Settling Parties shall submit this Stipulation together with its exhibits to the Court and shall
jointly apply for entry of an order (the &ldquo;Preliminary Approval Order&rdquo;), substantially in the form of Exhibit&nbsp;E attached
hereto, requesting: (i)&nbsp;preliminary approval of the Settlement set forth in this Stipulation; (ii)&nbsp;approval of the form and
manner of providing notice of the Settlement to Current Tactile Shareholders; and (iii)&nbsp;a date for the Settlement Hearing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
notice to Current Tactile Shareholders of the Settlement shall consist of a Notice of Pendency and Proposed Settlement of Shareholder
Derivative Action and of Settlement Hearing (&ldquo;Notice&rdquo;), which includes the general terms of the Settlement set forth in this
Stipulation and the date of the Settlement Hearing, substantially in the form attached hereto as Exhibit&nbsp;C, as well as a Summary
Notice of Pendency and Proposed Settlement of Shareholder Derivative Action and of Settlement Hearing (&ldquo;Summary Notice&rdquo;),
substantially in the form attached hereto as Exhibit&nbsp;D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Tactile
shall undertake the administrative responsibility for giving notice to Current Tactile Shareholders of the Settlement as detailed in this
paragraph. Within fourteen (14) days after the entry of the Preliminary Approval Order, Tactile shall: (i)&nbsp;publish the Summary Notice
once in <I>Investor's Business Daily</I> or a similar online publication; (ii)&nbsp;post the Notice and this Stipulation (with the exhibits
hereto) on the &ldquo;Investors&rdquo; portion of the Company&rsquo;s website; and (iii)&nbsp;file with the U.S. Securities and Exchange
Commission a Current Report on Form&nbsp;8-K attaching the Notice and this Stipulation (with the exhibits hereto). The Summary Notice
and Notice shall provide a link to the Investors portion of Tactile&rsquo;s website where the Notice and Stipulation (with the exhibits
hereto) may be viewed, which link shall be maintained through the date of the Settlement Hearing. Tactile or its insurers shall pay for
the costs associated with this notice program or any other form and manner of notice required by the Court. The Settling Parties believe
the content and manner of the notice of the Settlement, as set forth in this paragraph, constitutes adequate and reasonable notice to
Current Tactile Shareholders pursuant to applicable law and due process. Tactile&rsquo;s Counsel shall file with the Court an appropriate
affidavit or declaration with respect to filing and posting the Notice and Summary Notice within twenty-one (21) days after the entry
of the Preliminary Approval Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Pending
the Effective Date, all proceedings in the Derivative Action shall be stayed. <FONT STYLE="color: #030303">Consideration of the Litigation
Demand, the response by Tactile thereto, and any activity related to that demand shall also be stayed.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">After
an order of Preliminary Approval is entered counsel for Plaintiff shall prepare and file all necessary applications for final approval
of settlement and award of fees costs and award to Plaintiff following the schedule set forth by the Court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Pending
the Court&rsquo;s determination as to final approval of the Settlement, Plaintiff, Demand Shareholder, and all Current Tactile Shareholders
are barred and enjoined from commencing, prosecuting, instigating, or in any way participating in the commencement or prosecution of
any action asserting any Released Claim against any of the Released Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Attorneys' Fees and Reimbursement of Expenses</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">After
negotiation of the principal terms of the Settlement, including the Reforms, the Settling Parties engaged in several months of additional
negotiations concerning an appropriate fee and expense award for Plaintiffs&rsquo; Counsel and Demand Shareholder&rsquo;s Counsel. These
negotiations ultimately culminated in the agreed-to amount of $485,000.00, inclusive of fees and costs (the &ldquo;Fee and Expense Amount&rdquo;).
The Fee and Expense Amount is subject to Court approval and Defendants have agreed that they will not oppose or object to the Fee and
Expense Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Court may consider and rule&nbsp;upon the fairness, reasonableness, and adequacy of the proposed Settlement independently of the proposed
Fee and Expense Amount. The failure of the Court to approve the proposed Fee and Expense Amount, in whole or in part, shall have no effect
on the validity of the Settlement or delay the enforceability of the Settlement, and final resolution by the Court of the proposed Fee
and Expense Amount shall not be a precondition to the dismissal with prejudice of the Derivative Action. Any failure of the Court to
approve the proposed Fee and Expense Amount, in whole or in part, shall not provide any of the Settling Parties with the right to terminate
the Settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
amount awarded by the Court shall be paid by Tactile or its insurers into an escrow account of Squitieri&nbsp;&amp; Fearon, LLP on behalf
of Plaintiff's Counsel and Demand Shareholder&rsquo;s Counsel in the amount ordered by the Court within twenty (20) business days of
the later of Court approval of the Fee and Expense Amount and provision by Plaintiff&rsquo;s Counsel of all required funding information
and tax identification numbers, and shall be immediately releasable to Plaintiff's Counsel notwithstanding the existence of any collateral
attacks on the Settlement, including without limitation, any objections or appeals, subject to Plaintiff&rsquo;s Counsel&rsquo;s obligations,
which shall be joint and several as to each law firm that comprise Plaintiff&rsquo;s Counsel, (i)&nbsp;to return all released fees and
expenses within thirty (30) days following notice that the Settlement has failed to become or is no longer effective; and (ii)&nbsp;to
refund any amount by which the award of such fees and expenses is reduced within thirty (30) days following notice of such reduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Fee and Expense Amount, once paid, shall fully satisfy any and all claims against the Released Defendant Persons for an award of attorneys&rsquo;
fees and expenses by Plaintiff, Plaintiff&rsquo;s Counsel, the Demand Shareholder, the Demand Shareholder&rsquo;s Counsel, or any other
counsel purporting to represent any other Tactile stockholder in connection with or related to the Derivative Action, the Settlement,
the Litigation Demand, and the Released Plaintiff Claims.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Defendants
shall have no responsibility for, and no liability with respect to, the allocation of the attorneys&rsquo; fees awarded among Plaintiff&rsquo;s
Counsel, Demand Shareholder&rsquo;s Counsel, and/or to any other person who may assert some claim thereto.&nbsp; Any dispute regarding
any allocation of the Fee and Expense Amount among Plaintiff's Counsel and/or Demand Shareholder&rsquo;s Counsel shall have no effect
on the Settlement, and such dispute shall be finally decided and resolved by Michelle Yoshida of Phillips ADR Enterprises (the &ldquo;Mediator&rdquo;)
on the terms and subject to the process and procedures set forth by the Mediator. The Mediator&rsquo;s fees and costs for any mediation
and/or arbitration regarding allocation of the Fee and Expense Amount among Plaintiff&rsquo;s Counsel and Demand Shareholder&rsquo;s Counsel
shall be borne solely by Plaintiff&rsquo;s Counsel and Demand Shareholder&rsquo;s Counsel and allocated among Plaintiff&rsquo;s Counsel
and Demand Shareholder&rsquo;s Counsel by agreement or as finally determined by the Mediator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Plaintiff&rsquo;s
Counsel may apply to the Court for a service award of up to $7,500 for the Plaintiff and the Demand Shareholder, only to be paid upon
Court approval, and to be paid from the Fee and Expense Amount in recognition of Plaintiff&rsquo;s and Demand Shareholder&rsquo;s participation
and effort in the prosecution of the Derivative Action and the Litigation Demand. The failure of the Court to approve any requested service
award, in whole or in part, shall have no effect on the Settlement set forth in this Stipulation. Neither Tactile nor any of the Individual
Defendants shall be directly liable for any portion of any service award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Nothing
in this Stipulation expands, augments, alters, restricts, curtails or limits the indemnification obligations of Tactile to the Individual
Defendants, and nothing in this Stipulation expands, augments, alters, restricts, curtails or limits the obligations of the insurers,
on the one hand, to Tactile or the Released Defendant Persons, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Releases</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the Effective Date, <FONT STYLE="color: #231f20">Plaintiff</FONT> (acting on his own behalf and/or derivatively on behalf of Tactile),
Demand Shareholder, Tactile, and any Person acting or purporting to act derivatively on behalf of Tactile shall be deemed to have, and
by operation of the Judgment shall have, fully, finally, and forever released, relinquished, discharged and dismissed with prejudice the
Released Plaintiff Claims (including Unknown Claims) against the Released Defendant Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the Effective Date, <FONT STYLE="color: #231f20">Plaintiff</FONT> (acting on his own behalf and/or derivatively on behalf of Tactile),
Demand Shareholder, Tactile, and any Person acting or purporting to act derivatively on behalf of Tactile, shall be forever barred and
enjoined from asserting, commencing, instituting, or prosecuting any of the Released Plaintiff Claims against any Released Defendant
Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the Effective Date, each of the Individual Defendants and Tactile shall be deemed to have, and by operation of the Judgment shall have,
fully, finally, and forever released, relinquished, and discharged the Released Defendant Claims (including Unknown Claims) against the
Released Plaintiff Persons, and shall be forever barred and enjoined from asserting any Released Defendant Claims against any Released
Plaintiff Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Nothing
herein shall in any way impair or restrict the rights of any Settling Party to enforce the terms of this Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
entry and approval of the Judgment shall cause the Derivative Action to be dismissed with prejudice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD STYLE="text-align: justify"><B>Conditions of Settlement; Effect of Disapproval, Cancellation, or Termination</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Effective Date of this Stipulation shall be conditioned on the occurrence of all of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Court
approval of the Settlement and approval of the content and method of providing Notice of the proposed Settlement to Current Tactile Shareholders,
and the subsequent dissemination of the Notice to Current Tactile Shareholders;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Court
entry of the Judgment, in all material respects in the form set forth as Exhibit&nbsp;B annexed hereto, approving the Settlement and dismissing
the Derivative Action with prejudice, without awarding costs to any party, except as provided herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
passing of the date upon which the Judgment becomes Final.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
any of the conditions specified above in paragraph 6.1 are not met, then this Stipulation shall be canceled and terminated subject to
paragraph 6.3, unless counsel for the Settling Parties mutually agree in writing to proceed with this Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
for any reason the Effective Date of this Stipulation does not occur, or if this Stipulation is in any way canceled, terminated or fails
to become Final in accordance with its terms: (a)&nbsp;all Settling Parties and Released Persons shall be restored to their respective
positions as of October&nbsp;26, 2023 (the date of the Term Sheet); (b)&nbsp;all releases delivered in connection with this Stipulation
shall be null and void, except as otherwise provided for in this Stipulation; (c)&nbsp;the Fee and Expense Amount paid to Plaintiff's
Counsel shall be refunded and returned within thirty (30) days (consistent with paragraph 4.3 above); and (e)&nbsp;all negotiations, proceedings,
documents prepared, and statements made in connection herewith shall be without prejudice to the Settling Parties, shall not be deemed
or construed to be an admission by a Settling Party of any act, matter, or proposition, and shall not be used in any manner for any purpose
in any subsequent proceeding in the Derivative Action or in any other action or proceeding. In such event, the terms and provisions of
this Stipulation shall have no further force and effect (other than those set forth in paragraph 6.2 hereof) with respect to the Settling
Parties and shall not be used in the Derivative Action or in any other proceeding for any purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>Miscellaneous Provisions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Settling Parties: (a)&nbsp;acknowledge that it is their intent to consummate this Stipulation; and (b)&nbsp;agree to act in good faith
and cooperate to take all reasonable and necessary steps to expeditiously implement the terms and conditions of this Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any part of the Settlement is found to be unlawful, void, unconscionable, or against public policy by a court of competent
jurisdiction, the remaining terms and conditions of the Settlement shall remain intact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Settling Parties intend this Settlement to be a final and complete resolution of all disputes between them with respect to the Derivative
Action and the Litigation Demand. The Settlement comprises claims that are contested and shall not be deemed an admission by any Settling
Party as to the merits of any claim, allegation, or defense. The Settling Parties and their respective counsel agree that at all times
during the course of the litigation, each has complied with the requirements of the applicable laws and rules&nbsp;of the Court, including,
without limitation, Rule&nbsp;11 of the Federal Rules&nbsp;of Civil Procedure, and all other similar laws and/or rules&nbsp;governing
professional conduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Individual Defendants expressly denies and continues to deny all allegations of wrongdoing or liability against himself or herself
arising out of any conduct, statements, acts, or omissions alleged, or which could have been alleged, in the Derivative Action or the
Litigation Demand. The existence of the provisions contained in this Stipulation shall not be deemed to prejudice in any way the respective
positions of the Settling Parties with respect to the Derivative Action or the Litigation Demand, shall not be deemed a presumption, a
concession, or admission by any of the Settling Parties of any fault, liability, or wrongdoing as to any facts, claims, or defenses that
have been or might have been alleged or asserted in the Derivative Action or the Litigation Demand or with respect to any of the claims
settled in the Derivative Action, the Litigation Demand, or any other action or proceeding, and shall not be interpreted, construed, deemed,
invoked, offered, or received in evidence or otherwise used by any person in the Derivative Action, or in any other action or proceeding,
except for any litigation or judicial proceeding arising out of or relating to this Stipulation or the Settlement whether civil, criminal,
or administrative, for any purpose other than as provided expressly herein. Notwithstanding the foregoing, any of the Released Defendant
Persons may file this Stipulation or any judgment or order of the Court related hereto in order to support any and all defenses or counterclaims
based on res judicata, collateral estoppel, good faith settlement, judgment bar or reduction or any other theory of claim preclusion or
issue preclusion or similar defense or counterclaim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Plaintiff
and Plaintiff&rsquo;s Counsel represent and warrant that: (i)&nbsp;Plaintiff is a current stockholder of Tactile; (ii)&nbsp;none of the
Released Plaintiff Claims has been assigned, encumbered or in any manner transferred, in whole or in part, by Plaintiff or Plaintiff&rsquo;s
Counsel; and (iii)&nbsp;neither Plaintiff nor Plaintiff&rsquo;s Counsel will attempt to assign, encumber or in any manner transfer, in
whole or in part, any of the Released Plaintiff Claims.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Demand
Shareholder and Demand Shareholder&rsquo;s Counsel warrant that: (i)&nbsp;Demand Shareholder is a current stockholder of Tactile; (ii)&nbsp;none
of the Released Plaintiff Claims has been assigned, encumbered or in any manner transferred, in whole or in part, by Demand Shareholder
or Demand Shareholder&rsquo;s Counsel; and (iii)&nbsp;neither Demand Shareholder nor Demand Shareholder&rsquo;s Counsel will attempt to
assign, encumber or in any manner transfer, in whole or in part, any of the Released Plaintiff Claims.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
planned, proposed, or actual sale, merger, or change-in-control of Tactile shall not void this Stipulation. The Stipulation shall run
to the Settling Parties&rsquo; respective successors-in-interest. In the event of a planned, proposed, or actual sale, merger, or change-in-control
of Tactile, the Settling Parties shall continue to seek court approval of the Settlement expeditiously, including, but not limited to,
the Settlement terms reflected in this Stipulation and the Fee and Expense Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event any proceedings by or on behalf of Tactile, whether voluntary or involuntary, are initiated under any chapter of the United
States Bankruptcy Code, including an act of receivership, asset seizure, or similar federal or state law action (&ldquo;Bankruptcy Proceedings&rdquo;),
the Settling Parties agree to use their reasonable best efforts to obtain all necessary orders, consents, releases, and approvals for
effectuation of this Stipulation in a timely and expeditious manner. In the event of any Bankruptcy Proceedings by or on behalf of Tactile,
the Settling Parties agree that all dates and deadlines set forth herein will be extended for such periods of time as are necessary to
obtain necessary orders, consents, releases and approvals from the bankruptcy court to carry out the terms and conditions of the Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Stipulation may be modified or amended only by a writing signed by the signatories hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Stipulation shall be deemed drafted equally by all Settling Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
representations, warranties, or inducements have been made to any of the Settling Parties concerning this Stipulation or its exhibits
other than the representations, warranties, and covenants contained and memorialized in such documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
counsel or other Person executing this Stipulation or its exhibits on behalf of any of the Settling Parties hereby warrants that such
Person has the full authority to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
exhibits to this Stipulation are material and integral parts hereof and are fully incorporated herein by this reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.14</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Stipulation and the exhibits attached hereto constitute the entire agreement among the Settling Parties with respect to the subject matter
hereof and supersede all prior and contemporaneous oral and written agreements and discussions, including the Term Sheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.15</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that there exists a conflict or inconsistency between the terms of this Stipulation and the terms of any exhibit hereto, the
terms of this Stipulation shall prevail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.16</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Stipulation may be executed in one or more counterparts, including by signature transmitted by facsimile or e-mailed PDF files. Each counterpart,
when so executed, shall be deemed to be an original, and all such counterparts together shall constitute the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.17</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
rights and obligations of the parties to this Stipulation shall be construed and enforced in accordance with, and governed by, the internal,
substantive laws of the State of Delaware without giving effect to that State's choice of law principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.18</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Court shall retain jurisdiction to implement and enforce the terms of the Stipulation and the Court's Judgment and to consider any matters
or disputes arising out of or relating to the Settlement, and the Settling Parties submit to the jurisdiction of the Court for purposes
of implementing and enforcing the Settlement embodied in the Stipulation and Judgment, and for matters or disputes arising out of or relating
to the Settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Settling
Parties have caused this Stipulation to be executed by their duly authorized attorneys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED:&nbsp;&nbsp;June&nbsp;6, 2024</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 51%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Seth Rigrodsky</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Seth Rigrodsky (#3147)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Herbert W. Mondros (#3308)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gina M. Serra (#5387)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>RiGroDsky Law, P.A.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">300 Delaware Ave., Suite&nbsp;210</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wilmington, Delaware 19801</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(302) 295-5306</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Lee Squitieri</I></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lee Squitieri</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SQUITIERI&nbsp;&amp; FEARON, LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">305 Broadway</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7th Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10007</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(212) 421-6492</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Fletcher Moore</I></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fletcher Moore</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Justin Kuehn</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MOORE KUEHN, PLLC</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">30 Wall Street, 8th Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10011</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(212) 709-8245</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Counsel for Plaintiff </I></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED:&nbsp;&nbsp;June&nbsp;6,
    2024</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ <I>Brett D. Stecker</I></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Brett
                                       D. Stecker</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal">SHUMAN,
    GLENN&nbsp;&amp; STECKER</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">326
    W. Lancaster Avenue</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Ardmore,
    PA 19003</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">(303)
    861-3003</FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Counsel for Demand
    Shareholder</U></I></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED: June&nbsp;6, 2024</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 51%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Joseph C. Schoell</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Joseph C. Schoell (#3133)<BR>
    <B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">222 Delaware Avenue, Suite&nbsp;1410</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wilmington, Delaware 19801</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(302) 467-4200</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">joseph.schoell@faegredrinker.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matthew Kilby (<I>pro hac vice</I>)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rory F. Collins (<I>pro hac vice</I>)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anderson Tuggle (<I>pro hac vice</I>)<BR>
    <B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH LLP</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2200 Wells Fargo Center<BR>
    99 South Seventh Street<BR>
    Minneapolis, MN 55402</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(612) 766-7000<BR>
    matthew.kilby@faegredrinker.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">rory.collins@faegredrinker.com<BR>
    anderson.tuggle@faegredrinker.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Counsel for Defendants</I></P></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #030303"><B><U>EXHIBIT&nbsp;A</U></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CORPORATE GOVERNANCE REFORMS</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a part of the settlement of the derivative action
brought by Plaintiff and the release of claims by Demand Shareholder, defendant Tactile Systems Technology,&nbsp;Inc. (&ldquo;Tactile&rdquo;
or the &ldquo;Company&rdquo;) shall implement certain corporate governance reforms at the Company, adopt resolutions, amend committee
Charters and/or its Corporate Governance Guidelines and/or applicable corporate policies to ensure adherence to the following Corporate
Governance Reforms, which shall be maintained for no less than three (3)&nbsp;years from implementation of the changes.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #030303">Defendant</FONT>s
Brent Moen, William Burke, Peter Soderberg, Raymond Huggenberger, Richard Nigon, Kevin Roche, Lynn Blake, Gerald Mattys, Robert Folkes,
and Bryan Rishe (the &ldquo;Individual Defendants&rdquo;), and Nominal Defendant Tactile <FONT STYLE="color: #030303">acknowledge that
Plaintiff&rsquo;s and Demand </FONT>Shareholder&rsquo;s <FONT STYLE="color: #030303">efforts, including, but not limited to, efforts in
investigating, preparing, commencing, and prosecuting this Derivative Action and the Demand </FONT>Shareholder&rsquo;s <FONT STYLE="color: #030303">Litigation
Demand, were a material cause for the implementation of these Corporate Governance Reforms and the Insider Trading Policy effective </FONT>March&nbsp;7,
2023<FONT STYLE="color: #030303">, and that these Corporate Governance Reforms confer substantial benefits on the Company and its </FONT>shareholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>I.</B></TD><TD STYLE="text-align: justify"><B>THE COMPANY SHALL APPOINT ONE INDEPENDENT DIRECTOR TO THE DISCLOSURE COMMITTEE</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Currently, the Company maintains a corporate level
Disclosure Committee. The Disclosure Committee is tasked with reviewing and approving the public disclosures made by Tactile in the Company&rsquo;s
Form&nbsp;10-K and Form&nbsp;10-Q filings with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), to ensure they are complete
and accurate so that Tactile stockholders and potential Tactile investors are truthfully and timely informed as to the operations and
financial situation of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Currently, the Disclosure Committee is strictly
a management level committee, wherein all members are employees of Tactile. As consideration for settlement of the claims, the Board shall
modify this structure and appoint one independent director (per the director independence standards established by NASDAQ) of the Company
to serve as an ex-officio member of the Disclosure Committee. Thereafter, the independent director who serves on the Disclosure Committee
shall attend pre-filing Disclosure Committee meetings where practicable, and will have primary responsibility for bringing any issues
raised by the Board regarding the adequacy of Tactile&rsquo;s public disclosures to the Disclosure Committee, CEO, or CFO on a timely
basis. Similarly, the independent director serving ex-officio on the Disclosure Committee will also report periodically to the full Board
regarding the issues discussed by the Disclosure Committee. In addition, the director serving as a member of the Disclosure Committee
will facilitate the upward and downward flow of information regarding the Company&rsquo;s public disclosures between the Board and senior
management on the Disclosure Committee and/or the CEO and CFO.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>II.</B></TD><TD STYLE="text-align: justify"><B>THE COMPANY SHALL APPOINT A CHIEF COMPLIANCE OFFICER</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board shall direct Tactile to create the management
level position of Chief Compliance Officer (&ldquo;CCO&rdquo;), who shall be an executive level employee. In addition to other reporting
obligations the CCO may have, the CCO will report directly to the Board&rsquo;s Compliance and Reimbursement Committee (the &ldquo;Compliance
Committee&rdquo;) and, as necessary, the Audit Committee or the Corporate Governance and Nominating Committee (the &ldquo;Corporate Governance
Committee&rdquo;). The purposes of the CCO shall include, but not be limited to, (i)&nbsp;managing and overseeing Tactile&rsquo;s ethics
and compliance program, including implementing procedures for monitoring and evaluating the program&rsquo;s performance, and, where necessary,
recommending appropriate remedial action(s); (ii)&nbsp;fostering a culture that integrates compliance and ethics into business processes
and practices through awareness and training, including training on Tactile&rsquo;s Code of Business Conduct and Ethics; (iii)&nbsp;working
with the Compliance Committee to evaluate and define the goals of Tactile&rsquo;s ethics and compliance program in light of legal or regulatory
trends and changes which may affect Tactile&rsquo;s compliance with federal healthcare laws, and in particular the federal Anti-Kickback
Statute (the &ldquo;AKS&rdquo;), the federal False Claims Act (the &ldquo;FCA&rdquo;), and Medicare reimbursement regulations; and (iv)&nbsp;except
for concerns under review by the Board or any Board committee, reporting and overseeing investigations of potential compliance and ethics
concerns (delegating as appropriate).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The CCO shall be primarily responsible for managing
Tactile&rsquo;s compliance program, and for assisting the Board in fulfilling its oversight duties, in connection with Tactile&rsquo;s
compliance with federal and/or state healthcare laws (including federal Medicare reimbursement regulations, the AKS, the Stark Law, and
the FCA) and with Tactile&rsquo;s Code of Business Conduct and Ethics. In this regard, the CCO shall serve as a member of the Disclosure
Committee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The CCO will provide a report to the Compliance
Committee at least two (2)&nbsp;times annually, and will address, <I>inter alia</I>, any compliance or ethics concerns the CCO believes
should be raised with the Compliance Committee regarding federal and/or state healthcare laws (including federal Medicare reimbursement
regulations, AKS, the Stark Law, and the FCA) or Tactile&rsquo;s Code of Business Conduct and Ethics. The CCO will also meet with the
Compliance Committee periodically to review ongoing litigation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The independent members of the Board may review
with the CCO any concerns, including any pending compliance issues raised by any government or regulatory agencies that fall under the
CCO&rsquo;s purview; the Company&rsquo;s compliance with the AKS, the FCA, and Medicare reimbursement regulations; and the effectiveness
of the Company&rsquo;s policies, procedures, systems, and controls designed to ensure legal and regulatory compliance.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>III.</B></TD><TD STYLE="text-align: justify"><B>CODIFICATION OF NON-EXECUTIVE CHAIR OF THE BOARD</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Corporate governance guidelines shall be amended
to require the Board to appoint an independent director to be the Board Chair, or to appoint a Lead Independent Director. The Board Chair
or Lead Independent Director shall be primarily responsible for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">1.</TD><TD STYLE="text-align: justify">Working directly with the Company&rsquo;s CEO to ensure the preparation of meeting agendas, materials, and schedules, and seeking
input from all directors as to the preparation of the agendas for Board and committee meetings;</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">2.</TD><TD STYLE="text-align: justify">Moderating executive sessions of the Board, and acting (or delegating to another member of the Board to act) as principal liaison
between the Board and management on relevant matters discussed in executive session;</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">3.</TD><TD STYLE="text-align: justify">Regularly consulting with the respective Chairpersons of the Audit Committee, the Compensation and Organization Committee (the &ldquo;Compensation
Committee&rdquo;), the Compliance Committee, and the Corporate Governance Committee;</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">4.</TD><TD STYLE="text-align: justify">Managing the Company&rsquo;s evaluation of the CEO&rsquo;s performance.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>IV.</B></TD><TD STYLE="text-align: justify"><B>BOARD INFORMATION ACCESS</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board shall adopt a policy whereby all directors
shall be provided with all Board materials to be discussed at a regularly scheduled Board meeting, whether in person, telephonic, or virtual,
in a timely manner prior to formal Board meetings. The purpose of this policy is to ensure that all directors of the Company are provided
adequate time to meaningfully review relevant materials and to have a reasonable opportunity to request additional information from relevant
employees or third parties prior to formal Board meetings.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>V.</B></TD><TD STYLE="text-align: justify"><B>CORPORATE GOVERNANCE GUIDELINE PUBLICATION</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with its duties to develop and recommend
Corporate Governance Guidelines to the Board, the Corporate Governance Committee shall ensure that the Corporate Governance Guidelines,
and any amendments thereto, are promptly made available to the public, through the Company's website or otherwise.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>VI.</B></TD><TD STYLE="text-align: justify"><B>DIRECTOR ATTENDANCE AT STOCKHOLDER MEETINGS</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board shall adopt a policy which expects the
attendance of all directors, remotely or in person, at all stockholder meetings including, but not limited to, the Company&rsquo;s Annual
Meeting of Stockholders, subject to unavoidable scheduling conflicts.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>VII.</B></TD><TD STYLE="text-align: justify"><B>PUBLIC POSTING OF CORPORATE GOVERNANCE DOCUMENTS, COMPENSATION CLAWBACK AND INSIDER TRADING POLICIES</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company will post Tactile&rsquo;s
Board committee charters, Code of Business Conduct and Ethics, Corporate Governance Guidelines,&nbsp;Insider Trading Policy, and compensation
clawback policy on the Company&rsquo;s public website in an easily accessible location.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.15in"></TD><TD STYLE="text-align: justify; width: 0.35in"><B>VIII.</B></TD><TD STYLE="text-align: justify"><B>INSIDER TRADING</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Tactile acknowledges that it updated its insider
trading policy effective March&nbsp;7, 2023 due in part to this Derivative Action, which includes a cooling-off period for Rule&nbsp;10b5-1
plans of at least the minimum period required under Rule&nbsp;10b5-1(c)&nbsp;and a prohibition on exercising influence over securities
subject to such a plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Tactile will implement mandatory training on its
revised insider trading policy effective March&nbsp;7, 2023 for employees and new hires to be completed within six months of starting
their employment.&nbsp; Each employee shall attest that they have been made aware of the insider trading policy effective March&nbsp;7,
2023 and will abide by the terms, conditions and prohibitions therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #030303"><B><U>EXHIBIT&nbsp;B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES DISTRICT COURT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DISTRICT
OF </B></FONT><B>DELAWARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5pt 5.4pt; width: 35%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>JACK WEAVER, Derivatively on
    Behalf of TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Plaintiff,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">v.</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BRENT MOEN, et al.,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Defendants,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">-and-</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Nominal Defendant.</P></TD>
    <TD STYLE="padding: 5pt 5.4pt; width: 65%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASE
NO. </FONT>1:22-cv-01063-GBW</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[PROPOSED] ORDER AND FINAL JUDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This matter came before the
Court for a hearing pursuant to the Order of this Court entered on ____________ ____, 2024 (ECF No.&nbsp;__) (&ldquo;Preliminary Approval
Order&rdquo;), on the application of the Settling Parties for approval of the Settlement set forth in the Stipulation of Settlement executed
by counsel for the Parties as of June&nbsp;6, 2024 (the &ldquo;Stipulation&rdquo;). All capitalized terms used herein have the meanings
set forth and defined in the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Court has received a declaration
attesting to (1)&nbsp;the publication of the Summary Notice once in <I>Investor's Business Daily</I> or a similar online publication;
(ii)&nbsp;the posting of the Notice and the Stipulation (with the exhibits hereto) on the &ldquo;Investors&rdquo; portion of the Company&rsquo;s
website; and (iii)&nbsp;the filing with the U.S. Securities and Exchange Commission of a Current Report on Form&nbsp;8-K attaching the
Notice and the Stipulation (with the exhibits hereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Therefore, due and adequate
notice having been given to Current Tactile Shareholders as required by the Preliminary Approval Order, and the Court having considered
all papers filed and proceedings herein and otherwise being fully informed of the matters herein, and good cause appearing therefore,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IT IS HEREBY ORDERED, ADJUDGED
AND DECREED as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Court has jurisdiction over the subject matter of this Action, including the terms and conditions of the Stipulation and all exhibits
thereto, over the Settling Parties to the Stipulation, and over Current Tactile Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Based
on documents submitted by Tactile&rsquo;s counsel, the Court finds that the Summary Notice and Notice were posted and published according
to this Court&rsquo;s Preliminary Approval Order. This Court further finds that the form, content and manner of distribution of the Summary
Notice and Notice, as previously preliminarily approved by the Court, complied with the requirements of Federal Rules&nbsp;of Civil Procedure
23.1, satisfied the requirements of due process, and constituted due and sufficient notice of the matters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
full opportunity has been offered to Current Tactile Shareholders to object to the proposed Settlement and to participate in the hearing
thereon, and, as such, all Current Tactile Shareholders are bound by this Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Settlement is found to be fair, reasonable, adequate and in the best interests of Tactile and Current Tactile Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Court finds, for settlement purposes, that: (1)&nbsp;this action was properly brought as a shareholder derivative suit pursuant to Rule&nbsp;23.1
and (2)&nbsp;Plaintiff Weaver (&ldquo;Plaintiff&rdquo;), adequately represented the interests of Current Tactile Shareholders and Tactile
as a derivative Plaintiff in this suit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Stipulation and the terms of the proposed Settlement set forth therein are, in all respects, hereby finally approved. The Settling Parties
to the Stipulation are directed to consummate the Settlement in accordance with the terms and provisions of the Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
claims asserted in this Action as well as the Released Claims are hereby dismissed with prejudice in their entirety on the merits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the Effective Date, Plaintiff (acting on his own behalf and/or derivatively on behalf of Tactile), Cory Griffin (the &ldquo;Demand Shareholder&rdquo;),
Tactile, and any Person acting or purporting to act derivatively on behalf of Tactile shall be deemed to have, and by operation of the
Judgment shall have, fully, finally, and forever released, relinquished, discharged and dismissed with prejudice the Released Plaintiff
Claims (including Unknown Claims) against the Released Defendant Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the Effective Date, Plaintiff (acting on his own behalf and/or derivatively on behalf of Tactile), Demand Shareholder, Tactile, and any
Person acting or purporting to act derivatively on behalf of Tactile shall be forever barred and enjoined from asserting, commencing,
instituting, or prosecuting any of the Released Plaintiff Claims (including Unknown Claims) against any Released Defendant Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
the Effective Date, each of the Individual Defendants and Tactile shall be deemed to have, and by operation of the Judgment shall have,
fully, finally, and forever released, relinquished, and discharged the Released Defendant Claims (including Unknown Claims) against the
Released Plaintiff Persons, and shall be forever barred and enjoined from asserting any Released Defendant Claims against any Released
Plaintiff Person. For the avoidance of doubt, nothing in this Order expands, augments, alters, restricts, curtails or limits the indemnification
obligations of Tactile to the Individual Defendants, and nothing in this Order expands, augments, alters, restricts, curtails or limits
the obligations of the insurers, on the one hand, to Tactile or the Released Defendant Persons, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Plaintiff&rsquo;s
Counsel and Demand Shareholder&rsquo;s Counsel are hereby awarded attorneys&rsquo; fees and a reimbursement of expenses of $_________________
(&ldquo;Fee and Expense Amount&rdquo;). This Court finds that this amount is fair and reasonable under the facts and circumstances of
this case. Payment of such Fee and Expense Amount shall be made in accordance with the provisions of the Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Plaintiff
and Demand Shareholder are each granted a service award in the amount of $___________, which shall be funded from the Fee and Expense
Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Order and Final Judgment, the Stipulation and all of its provisions, and any negotiations, proceedings or agreements relating to the Stipulation
and the Settlement, and any matters arising in connection with such negotiations, proceedings or agreements, and any acts performed or
documents executed pursuant to or in furtherance of this Stipulation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not be offered or received against any of the Released Persons as evidence of a presumption, concession, or admission of any kind;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not be offered or received against any of the Released Persons as evidence of an admission by any of those Released Persons with respect
to the truth of any fact alleged in any of the Derivative Action or Litigation Demand or the validity of any Released Claim, or the deficiency
of any defense that has been or could have been asserted, or of any liability, negligence, fault, or wrongdoing of the Released Persons;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not be offered or received against the Released Persons as evidence of any fault, misrepresentation, omission or other actionable conduct
with respect to any statement or written document approved or made by any of the Released Persons;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not be offered or received against the Released Persons as evidence of any liability, negligence, fault or wrongdoing, or in any way referred
to for any other reason as against any of the Released Persons, in any other civil, criminal or administrative action or proceeding, other
than such proceedings as may be necessary to effectuate the provisions of this Stipulation; however, the Released Persons may refer to
the Stipulation to effectuate the release of Released Claims and other liability protections granted them hereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not be construed against any of the Released Persons as an admission or concession that the consideration to be given hereunder represents
the amount that could be or would have been recovered after trial;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not be construed as or received in evidence as an admission, concession or presumption against Plaintiff or Demand Shareholder that any
of their claims are without merit, or that any defenses asserted by the Defendants have any merit, or that damages recoverable in the
Derivative Action or Litigation Demand would not have exceeded the Settlement Amount; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
not, in the event the Stipulation and Settlement are disapproved, cancelled, or terminated (collectively, &ldquo;Termination&rdquo;),
be used by any Party for any purpose in any of the Derivative Action or Litigation Demand;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>provided
that</I>, any Party may file or introduce the Stipulation and/or the Order and Final Judgment in any action or proceeding that may be
brought to enforce the terms of the Stipulation and/or the Final Judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
in the event of a Termination, the Settling Parties agree not to assert under Rule&nbsp;11 of the Federal Rules&nbsp;of Civil Procedure
or any similar law, rule&nbsp;or regulation, that the Derivative Action or Litigation Demand were brought or defended in bad faith or
without a reasonable basis. The Settling Parties agree that the terms of this Settlement were negotiated at arms&rsquo; length and in
good faith by the Settling Parties and reflect a settlement that was reached voluntarily based upon adequate information and after consultation
with their respective experienced legal counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Without
in any way affecting the finality of this Order and Final Judgment, this Court shall retain jurisdiction over the Settling Parties to
the Stipulation and the Released Parties with respect to all matters related to the Derivative Action and Litigation Demand and to consider
any matters or disputes arising out of or relating to the Settlement, and the Settling Parties submit to the jurisdiction of the Court
for purposes of implementing and enforcing the Settlement embodied in the Stipulation and Order and Final Judgment, and for matters or
disputes arising out of or relating to the Settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
order regarding an award of attorneys&rsquo; fees and expenses, or any appeal, modification or change of such an order, shall in no way
disturb or affect the finality of this Order and Final Judgment and shall be considered separate from this Order and Final Judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Settlement shall be a final and complete resolution of all disputes among the Settling Parties. No party to the Stipulation may assert
in any forum that the Derivative Action or Litigation Demand were brought, commenced or prosecuted by the Plaintiffs or their counsel
in bad faith or that the Derivative Action or Litigation Demand were not filed or pursued in good faith or were not settled voluntarily
after negotiating at arm&rsquo;s-length and in good faith after consultation with competent legal counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Settling Parties are hereby authorized, without further approval of the Court, to unanimously agree to and adopt in writing such amendments,
modifications, and expansions of the Stipulation and all exhibits attached thereto, provided that such amendments, modifications, and
expansions of the Stipulation are done in accordance with the terms of the Stipulation, are not materially inconsistent with this Order
and Final Judgment and do not materially limit the rights of Current Tactile Shareholders or the Released Persons under the Stipulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that the Settlement does not become effective in accordance with the terms of the Stipulation, then this Order and Final Judgment
shall be rendered null and void to the extent provided by and in accordance with the Stipulation and shall be vacated, and in such event,
all orders entered and releases delivered in connection herewith shall be null and void to the extent provided by and in accordance with
the Stipulation, and the provisions of Paragraph 6.3 of the Stipulation shall apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
provisions of this Order and Final Judgment constitute a full and complete adjudication of the matters considered and adjudged herein,
and the Court determines that there is no just reason for delay in the entry of judgment. The Clerk is hereby directed to immediately
enter this Order and Final Judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SO ORDERED, THIS ___ day of ___________________,
2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Gregory B. Williams</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">United States District Judge</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #030303"><B><U>EXHIBIT&nbsp;C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF PENDENCY OF DERIVATIVE ACTION, PROPOSED<BR>
<U>AGREEMENT OF SETTLEMENT AND RELEASE, AND SETTLEMENT HEARING</U></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0"></TD><TD STYLE="text-align: justify; width: 0.5in"><B>TO:</B></TD><TD STYLE="text-align: justify"><B>ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. (&ldquo;TACTILE&quot;
OR THE &quot;COMPANY&quot;) AS OF JUNE 6, 2024 (THE &quot;RECORD DATE&quot;) (&quot;CURRENT TACTILE STOCKHOLDERS&quot;).</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>PLEASE READ THIS NOTICE
CAREFULLY AND IN ITS ENTIRETY. THIS <FONT STYLE="text-transform: uppercase">NOTICE RELATES TO A PROPOSED SETTLEMENT OF <I>WEAVER V. MOEN,
ET AL.</I>, CASE NO. 22-cv-01063 (the &ldquo;Action&rdquo; or &ldquo;derivative action&rdquo;), A SHAREHOLDER DERIVATIVE ACTION pending
in the united states district court for the district of delaware, AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS. IF THE COURT
APPROVES THE SETTLEMENT, YOU WILL BE FOREVER BARRED FROM CONTESTING THE APPROVAL OF THE PROPOSED SETTLEMENT AND FROM PURSUING THE &quot;RELEASED
CLAIMS,&quot; AS DEFINED IN THE STIPULATION.</FONT></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
ACTION IS <U>NOT</U> A &ldquo;CLASS&nbsp;ACTION.&rdquo; THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR A MONETARY
PAYMENT.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notice
is hereby provided to you of the proposed settlement (the &quot;Settlement&quot;) of this shareholder derivative lawsuit pursuant to Federal
Rule&nbsp;of Civil Procedure 23.1.<SUP>3</SUP></FONT> This Notice is provided by Order of the United States District Court for the District
of Delaware (the &quot;Court&quot;). It is not an expression of any opinion by the Court. It is to notify you of the terms of the proposed
Settlement, and your rights related thereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>WHY THE COMPANY HAS ISSUED THIS NOTICE</B></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
June&nbsp;6, 2024, Tactile, in its capacity as a nominal defendant, as well as certain current and former officers and directors of Tactile
who were named as individual defendants,<SUP>4</SUP> entered into a Stipulation of Settlement (the &quot;Stipulation&quot;)<SUP>5</SUP>
in the Derivative Action pending before the </FONT>Court, styled <I>Weaver v. Moen, et al</I>. The Stipulation also settles the Litigation
Demand.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>6</SUP></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="text-align: left; margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="text-align: justify; font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> A derivative lawsuit involves claims brought by a shareholder
on behalf of a company, rather than on behalf of himself or herself or the other shareholders of the company. The recovery in a derivative
action is for the benefit of the company rather than directly for individual shareholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>4</SUP> Specifically, Brent Moen, William Burke, Peter Soderberg,
Raymond O. Huggenberger, Richard Nigon, Kevin H. Roche, Lynn Blake, Gerald R. Mattys, Robert Folkes and Bryan F. Rishe (collectively,
the "Individual Defendants"; the Individual Defendants together with Tactile, the "Defendants").</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 12; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
terms of the Settlement are set forth fully in the Stipulation, which can be viewed and downloaded at <FONT STYLE="background-color: yellow">[insert
URL</FONT>]. </FONT>This Notice is a summary only and does not describe all of the details of the Stipulation and terms of the Settlement.
For full details of the matters discussed in this Notice, please review the Stipulation and visit <FONT STYLE="background-color: yellow">[URL].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On <FONT STYLE="background-color: yellow">[insert
date], at [insert time], in Courtroom [-]</FONT> of the Honorable Judge Gregory B. Williams, the Court will hold a hearing (the &quot;Settlement
Hearing&quot;), either in person, telephonically or via video. The purpose of the Settlement Hearing is to determine: (i)&nbsp;whether
the terms of the Settlement are fair, reasonable, and adequate and should be approved; (ii)&nbsp;whether a final judgment should be entered;
(iii)&nbsp;whether to approve Plaintiff&rsquo;s application for attorneys&rsquo; fees and reimbursement of expenses; and (iv)&nbsp;such
other matters as may be necessary or proper under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Summary of the Action</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>A.</B></TD><TD STYLE="text-align: justify"><B>The Now Settled Securities Class&nbsp;Actions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tactile, as well as certain
of its current and now former officers, were named as defendants in a federal securities fraud class action, entitled <I>Brian Mart,&nbsp;Individually
and on Behalf of All Others Similarly Situated v. Tactile Systems Technology,&nbsp;Inc., et al.</I>, No.&nbsp;0:20-cv-02074-NEB-BRT (D.
Minn. 2020) (the &ldquo;Securities Action&rdquo;). <FONT STYLE="background-color: white">On October&nbsp;18, 2022, the Securities Action
settled for a payment of $5 million to be distributed to buyers of Tactile stock during the Class&nbsp;Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">THIS
COURT HAS NO ROLE IN THE SECURITIES ACTION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>B.</B></FONT></TD><TD STYLE="text-align: justify"><B>Proceedings in Minnesota District Court Preceded The Action Here Being Settled</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&nbsp;24, 2022, Plaintiff
filed a shareholder derivative complaint on behalf of Tactile in the United States District Court for the District of Minnesota, pleading
claims against the Individual Defendants, including violations of section 14(a)&nbsp;of the Securities Exchange Act, rescind compensation
under section 29(b)&nbsp;of the Securities Exchange Act, rescind employment contract compensation under section 29(b)&nbsp;of the Securities
Exchange Act, contribution under 15 U.S.C. &sect; 77 k(f)&nbsp;and 21d(5)(a)-(d)&nbsp;and for violations of sections 10(b)&nbsp;and 21d
of the Securities Exchange Act, breach of fiduciary duty, and unjust enrichment. On August&nbsp;9, 2022, the case was transferred to this
Court upon joint motion and stipulation of the parties. The claims were based on similar facts and circumstances as the Securities Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>5
</SUP></FONT>This Notice should be read in conjunction with, and is qualified in its entirety by reference to, the text of the Stipulation,
which has been filed with the Court (Docket No. 22-cv-01063). A link to the Form 8-K filed with the U.S. Securities and Exchange Commission
(&quot;SEC&quot;) containing the text of the Stipulation may be found on the Company's website at the Investor Relations page at https<FONT STYLE="background-color: yellow">://investor.______________________.
</FONT>All capitalized terms herein have the same meanings as set forth in the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>6
</SUP></FONT>&ldquo;Litigation Demand&rdquo; means the demand served on Tactile and/or members of its Board of Directors on behalf of
stockholder Cory Griffin on September 2, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>C.</B></FONT></TD><TD STYLE="text-align: justify"><B>Proceedings in Delaware District Court</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the Action was transferred
to the Court, the litigation proceeded. On August&nbsp;25, 2022, the parties entered into a stipulation and [proposed] scheduling order
governing briefing on Defendants&rsquo; motion to stay. On September&nbsp;27, 2022, Defendants filed their motion and brief in support
of their motion to stay. On November&nbsp;14, 2022, Plaintiff filed his brief in opposition to Defendants&rsquo; motion to stay. On November&nbsp;30,
2022, Defendants filed their notice to withdraw motion to stay. On January&nbsp;31, 2023, the parties filed their stipulation for a briefing
schedule on Defendants&rsquo; motion to dismiss. On February&nbsp;10, 2023, Defendants filed their motion to dismiss for failure to state
a claim. On March&nbsp;6, 2023, Plaintiff filed his amended complaint in this Court pleading claims against the Individual Defendants,
including violations of section 14(a)&nbsp;of the Securities Exchange Act, rescind compensation under section 29(b)&nbsp;of the Securities
Exchange Act, rescind employment contract compensation under section 29(b)&nbsp;of the Securities Exchange Act, contribution under 15
U.S.C. &sect; 77 k(f)&nbsp;and 21d(5)(a)-(d)&nbsp;and for violations of sections 10(b)&nbsp;and 21d of the Securities Exchange Act, breach
of fiduciary duty, and unjust enrichment. On March&nbsp;31, 2023, Defendants filed their motion to dismiss the amended complaint. On April&nbsp;14,
2023, the parties filed their first joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss. On May&nbsp;3,
2023, the parties filed their second joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss. On June&nbsp;5,
2023, the parties filed their third joint stipulation extending the briefing schedule on Defendants&rsquo; motion to dismiss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><B>D.</B></TD><TD STYLE="text-align: justify"><B>The Extensive Settlement Negotiations</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Plaintiff&rsquo;s Counsel
engaged in extensive and ongoing settlement negotiations with the Defendants&rsquo; Counsel over the course of several months. On November&nbsp;11,
2022, Plaintiff made an initial settlement demand. On December&nbsp;26, 2022, Plaintiff agreed to invite the mediator who mediated the
Securities Action settlement to review their settlement demand. Over the next several months, the Settling Parties<SUP>7</SUP> exchanged
proposals and counter proposals and participated in multiple conference calls. Settlement discussions continued over the course of several
months and culminated in a comprehensive settlement term sheet on or about October&nbsp;26, 2023.. The Settling Parties have expended
significant time and resources participating in settlement communications in which the merits of the claims asserted in the Derivative
Action, as well as the defenses thereto, were extensively discussed between the Settling Parties. The Settling Parties have now reached
a definitive agreement to settle the Derivative Action, upon the terms and subject to the conditions set forth in the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>7
</SUP></FONT>As set forth in the Stipulation, &ldquo;Settling Parties&rdquo; refers to Plaintiff, Demand Shareholder, and Defendants,
collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>SETTLEMENT</B></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&nbsp;6, 2024, the
Plaintiff,<SUP>8</SUP> Demand Shareholder,<SUP>9</SUP> and Defendants entered into the Stipulation to resolve the Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Stipulation,
the Defendants shall cause Tactile to adopt, implement and maintain the corporate guidance provisions described in Rider A hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tactile</FONT>
and its Board acknowledged and agreed that Plaintiff&rsquo;s efforts, including his efforts in investigating, preparing, commencing, and
prosecuting the Derivative Action, was a material cause for the implementation of these reforms, and that the reforms confer substantial
benefits upon Tactile and its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Stipulation also provides
for the entry of judgment dismissing the Action against the Defendants with prejudice and, as explained fully in the Stipulation, releasing
and discharging certain known and unknown claims that could have been brought in any court, whether arising under federal, state, common,
or foreign law, which exist derivatively on behalf of Tactile, by Plaintiff or any other shareholder of Tactile that arise out of or relate
in any way to the claims asserted or that could have been asserted in any of the complaints in the Action, or the Litigation Demand, or
that arise out of, or relate in any way to the institution, prosecution, or settlement of the claims against the Defendants by Plaintiff
in the Action or Litigation Demand against Defendants, Tactile, and Tactile&rsquo;s past, present, and future officers and/or directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Plaintiff's Attorneys' Fees and Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After negotiating the financial
recovery and the corporate guidance provisions, the Settling Parties began negotiating the attorneys' fees that Tactile or Defendants&rsquo;
insurance carrier(s)&nbsp;would pay to Plaintiff&rsquo;s Counsel and Demand Shareholder&rsquo;s Counsel. In light of the substantial benefits
secured for Tactile by Plaintiff, Demand Shareholder, and their respective counsel in connection with the Settlement and the litigation
leading up to it, the Settling Parties have agreed that Plaintiff will seek an award of attorneys fees and expenses and service awards
for Plaintiff and Demand Shareholder not to exceed $485,000, all inclusive. Tactile has agreed that it or its insurers will pay any award
up to $485,000 but will not pay in connection with any request for fees from Plaintiff&rsquo;s counsel or Litigation Demand counsel which
exceeds $485,000. All of the foregoing is subject to Court approval. <FONT STYLE="background-color: white">Plaintiff's Counsel will request
Court approval for the payment to Plaintiff and Demand Shareholder of service awards in an amount not to exceed $7,500, subject to Court
approval, which will be funded from the Fee and Expense Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase; background-color: white"><B>Reasons for the Settlement</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">The
Court did not decide in favor of the Plaintiff or the Defendants. The proposed Settlement was negotiated at arm's-length by attorneys
representing the Settling Parties. The attorneys for all of the Settling Parties have extensive experience in shareholder derivative cases,
and they all believe the Settlement is in the best interest of their clients. Tactile and Plaintiff believes that the Settlement provides
substantial benefits upon Tactile and its shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>8
</SUP></FONT>As set forth in the Stipulation, &ldquo;Plaintiff&rdquo; refers to Jack Weaver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>9
</SUP></FONT>As set forth in the Stipulation, &ldquo;Demand Shareholder&rdquo; refers to Cory Griffin.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>5.1</B></FONT><B><FONT STYLE="background-color: white">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Why
Did the Plaintiff Agree to Settle?</FONT></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Plaintiff's
Counsel investigated claims and the underlying events and transactions alleged in the Action. Plaintiff's Counsel have analyzed the evidence
adduced during their investigation and have researched the applicable law with respect to the claims of Plaintiff, Tactile, and its shareholders
against the Defendants and the potential defenses thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Based
upon their investigation, Plaintiff and Plaintiff's Counsel have concluded that the terms and conditions of the Settlement are fair, reasonable,
and adequate to Plaintiff, current shareholders of Tactile, and Tactile, and in their best interests, and have agreed to settle the claims
raised in the Action pursuant to the terms and provisions of the Stipulation after considering, among other things: (a)&nbsp;the substantial
benefits that Tactile and its shareholders will receive from the Settlement; (b)&nbsp;the attendant risks of continued litigation of the
Action; and (c)&nbsp;the desirability of permitting the Settlement to be consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">In
particular, Plaintiff and Plaintiff's Counsel considered the significant litigation risk inherent in this Action. The law imposes significant
burdens on Plaintiff for pleading and proving a shareholder derivative claim. While Plaintiff believes his claims are meritorious, Plaintiff
acknowledges that there is a substantial risk that the Action may not succeed in producing a recovery in light of the applicable legal
standards and possible defenses. Plaintiff and Plaintiff's Counsel believe that, under the circumstances, they have obtained the best
possible relief for Tactile and its shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>5.2</B></FONT><B><FONT STYLE="background-color: white">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Why
Did the Defendants Agree to Settle?</FONT></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Individual Defendants have denied and continue to deny each and all of the claims and allegations alleged by Plaintiff in the Derivative
Action and Litigation Demand, and the Individual Defendants have expressly denied and continue to deny all charges of wrongdoing or liability
against them arising out of any of the conduct, statements, acts, or omissions alleged, or that could have been alleged in the Derivative
Action and Litigation Demand. The Individual Defendants believe that they have substantial defenses to the claims and allegations alleged
against them in the Derivative Action and Litigation Demand. The Individual Defendants believe that, at all relevant times, they acted
in good faith, and in a manner they reasonably believed to be in the best interests of Tactile and its stockholders. Nonetheless, the
Individual Defendants have also taken into account the uncertainty and risks inherent in any litigation, especially in complex cases like
the Derivative Action. The Individual Defendants have, therefore, determined that it is in the best interests of Tactile for the Derivative
Action and Litigation Demand to be settled in the manner and upon the terms and conditions set forth in this Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase; background-color: white"><B>Settlement Hearing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
<FONT STYLE="background-color: yellow">[insert date], at [insert time]</FONT>, in Courtroom <FONT STYLE="background-color: yellow">[-]
_____________________________________________,</FONT> the Court will hold the Settlement Hearing. At the Settlement Hearing, the Court
will consider whether the terms of the Settlement are fair, reasonable, and adequate and thus should be finally approved, and whether
the Action should be dismissed with prejudice pursuant to the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Right to Attend Settlement Hearing</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any
Current Tactile Shareholder may, but is not required to, appear in person at the Settlement Hearing. If you want to be heard at the Settlement
Hearing, then you must first comply with the procedures for objecting, which are set forth below. The Court has the right to change the
hearing dates or times without further notice. Thus, if you are planning to attend the Settlement Hearing, you should confirm the date
and time before going to the Court. CURRENT TACTILE SHAREHOLDERS WHO HAVE NO OBJECTION TO THE SETTLEMENT DO NOT NEED TO APPEAR AT THE
SETTLEMENT HEARING OR TAKE ANY OTHER ACTION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Right to Object to Settlement and Procedures for Doing So</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
have the right to object to any aspect of the Settlement. You must object in writing, and you may request to be heard at the Settlement
Hearing. If you choose to object, then you must follow these procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">You
Must Make Detailed Objections in Writing</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any
objection must be presented in writing and must contain the following information. The Court may not consider any objection that does
not substantially include the following information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">1)</TD><TD STYLE="text-align: justify">Your name, legal address, and telephone number;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">2)</TD><TD STYLE="text-align: justify">The case name and number (<I>Weaver v. Moen, et al.</I>, Case No.&nbsp;22-cv-01063);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">3)</TD><TD STYLE="text-align: justify">Proof of being a current Tactile stockholder as of the Record Date, June&nbsp;6, 2024;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">4)</TD><TD STYLE="text-align: justify">The date(s)&nbsp;you acquired your Tactile shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">5)</TD><TD STYLE="text-align: justify">A statement of your position regarding the matters to be heard the Settlement Hearing, including the grounds
for each objection or the reasons you desire to appear and be heard;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">6)</TD><TD STYLE="text-align: justify">Notice of whether you intend to appear at the Settlement Hearing (though attendance is not required if
you have lodged your objection);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">7)</TD><TD STYLE="text-align: justify">Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intent
to call to testify at the Settlement Hearing and the subject(s)&nbsp;of any expected testimony;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">8)</TD><TD STYLE="text-align: justify">The identities of any cases, by name, court, and docket number, in which the objector or his, her, or
its attorney has objected to a settlement in the last three years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">You
Must Timely Deliver Written Objections to the Court, Plaintiff's Counsel, and Defendants' Counsel</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">YOUR
WRITTEN OBJECTIONS MUST BE ON FILE WITH THE CLERK OF THE COURT NO LATER THAN 20 CALENDAR DAYS BEFORE THE SETTLEMENT HEARING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Court Clerk's Address is: United States District Court, District of Delaware, 844 North King Street, Unit 18, Wilmington, Delaware 19801-3570.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">YOU
ALSO MUST DELIVER COPIES OF THE MATERIALS TO COUNSEL FOR PLAINTIFF AND COUNSEL FOR TACTILE SO THEY ARE RECEIVED NO LATER THAN 20 CALENDAR
DAYS BEFORE THE SETTLEMENT HEARING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><B>Counsel for Plaintiff:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Lee Squitieri</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><B>SQUITIERI&nbsp;&amp; FEARON, LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">305 Broadway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">7th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, New York 10007</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">(212) 421-6492</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><B>Attorneys for Defendants
Tactile:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Joseph C. Schoell (#3133)<BR>
<B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">222 Delaware Avenue,
Suite&nbsp;1410</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Wilmington, Delaware
19801</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(302) 467-4200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">joseph.schoell@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Matthew Kilby (<I>pro hac vice</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Rory F. Collins (<I>pro hac vice</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">Anderson Tuggle (<I>pro hac vice</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH
LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">2200 Wells Fargo Center<BR>
99 South Seventh Street<BR>
Minneapolis, MN 55402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">(612) 766-7000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">matthew.kilby@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">rory.collins@faegredrinker.com<BR>
anderson.tuggle@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="text-transform: uppercase"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>How to Obtain More Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Notice summarizes the
Settlement. It is not a complete statement of the events of the Action, the Settlement, or the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may inspect the Stipulation
and other papers in the Action at the Clerk of the Court, 844 North King Street, Unit 18, Wilmington, Delaware 19801-3570, at any time
during regular business hours of each business day. You may also visit [insert link].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">PLEASE
DO NOT CALL, WRITE, OR OTHERWISE DIRECT QUESTIONS TO EITHER THE COURT OR THE CLERK'S OFFICE. Any questions you have about matters in this
Notice should be directed by telephone to Lee Squitieri (</FONT><FONT STYLE="text-decoration: underline">lee@sfclasslaw.com</FONT>) at (212) 421-6492
or in writing to Squitieri&nbsp;&amp; Fearon, LLP, 305 Broadway, 7th Floor, New York, New York 10007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 7%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED:</FONT></TD><TD STYLE="text-align: justify; width: 93%">June&nbsp;6, 2024</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BY ORDER OF THE COURT UNITED STATES DISTRICT COURT
DISTRICT OF DELAWARE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;D</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF PENDENCY OF DERIVATIVE ACTION, PROPOSED<BR>
<U>AGREEMENT OF SETTLEMENT AND RELEASE, AND SETTLEMENT HEARING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>TO:</B></TD><TD STYLE="text-align: justify"><B>ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.
(&ldquo;TACTILE&quot; OR THE &quot;COMPANY&quot;) AS OF JUNE 6, 2024 (THE &quot;RECORD DATE&quot;) (&quot;CURRENT TACTILE SHAREHOLDERS&quot;).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>PLEASE READ THIS NOTICE
CAREFULLY AND IN ITS ENTIRETY. THIS <FONT STYLE="text-transform: uppercase">NOTICE RELATES TO A PROPOSED SETTLEMENT OF <I>WEAVER V. MOEN,
ET AL.</I>, Lead CASE NO. 22-cv-01063, A SHAREHOLDER DERIVATIVE ACTION pending in the united states district court for the district of
delaware, AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS. IF THE COURT APPROVES THE SETTLEMENT, YOU WILL BE FOREVER BARRED FROM
CONTESTING THE APPROVAL OF THE PROPOSED SETTLEMENT AND FROM PURSUING THE &quot;RELEASED CLAIMS,&quot; AS DEFINED HEREIN.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS ACTION IS <U>NOT</U> A &ldquo;CLASS&nbsp;ACTION.&rdquo;
THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR A MONETARY PAYMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PLEASE
TAKE NOTICE</B></FONT> that the above-captioned derivative action (the &ldquo;Derivative Action&rdquo;) is being settled on the terms
set forth in a Stipulation of Settlement, dated June&nbsp;6, 2024 (the &ldquo;Stipulation&rdquo;).<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>10</SUP></FONT>
Notice is hereby provided to you of the proposed settlement (the &ldquo;Settlement&rdquo;) of this shareholder derivative lawsuit pursuant
to Federal Rule&nbsp;of Civil Procedure 23.1.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>11</SUP></FONT> This Notice
is provided by Order of the United States District Court for the District of Delaware (the &ldquo;Court&rdquo;). It is not an expression
of any opinion by the Court. It is to notify you of the terms of the proposed Settlement, and your rights related thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
the terms of the Stipulation, as a part of the proposed Settlement, Tactile will adopt certain corporate governance enhancements (the
 &ldquo;Reforms&rdquo;). These Reforms are designed to address the claims asserted in the Derivative Action and Litigation Demand<SUP>12</SUP>
and plaintiff believes they will enhance Tactile&rsquo;s internal controls as </FONT>identified in Exhibit&nbsp;A attached to the Stipulation.
Tactile has agreed to maintain the Reforms for a period set forth in the Stipulation, and to take steps necessary to authorize adequate
funding for the costs of implementing and maintaining the Reforms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>10
</SUP></FONT>This Summary Notice should be read in conjunction with, and is qualified in its entirety by reference to, the text of the
Stipulation, which has been filed with the United States District Court for the District of Delaware. A link to the Form 8-K filed with
the SEC containing the text of the Stipulation may be found on the Company&rsquo;s website at the Investor Relations page at https://____________________________________.
All capitalized terms herein have the same meanings as set forth in the Stipulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>11
</SUP></FONT>A derivative lawsuit involves claims brought by a shareholder on behalf of a company, rather than on behalf of himself or
herself or the other shareholders of the company. The recovery in a derivative action is for the benefit of the company rather than directly
for individual shareholders.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On _________, 2024, at ___
_.m., the Court will hold a hearing (the &ldquo;Settlement Hearing&rdquo;) either in person, telephonically or via video. The purpose
of the Settlement Hearing is to determine (i)&nbsp;whether the Settlement is fair, reasonable and adequate; (ii)&nbsp;whether a final
judgment should be entered and the Derivative Action should be dismissed with prejudice pursuant to the Stipulation; (iii)&nbsp;whether
to approve up to $485,000.00 in attorneys' fees and expenses for Plaintiffs&rsquo; Counsel and Demand Shareholder&rsquo;s Counsel; and
(iv)&nbsp;such other matters as may be necessary or proper under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any Current Tactile Shareholder
that objects to the Settlement shall have a right to appear and to be heard at the Settlement Hearing, provided that he, she or it was
a stockholder of record or beneficial owner as of June&nbsp;6, 2024. Any Current Tactile Shareholder who satisfies this requirement may
enter an appearance through counsel of such shareholder&rsquo;s own choosing and at such shareholder&rsquo;s own expense, or may appear
on their own. However, no Current Tactile Shareholder shall be heard at the Settlement Hearing unless, no later than ________________,
2024, such shareholder has filed with the Court, a written notice of objection containing the following information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Your name, legal address, and telephone number;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">The case name and number (<I>Weaver v. Moen, et al.</I>, Case No.&nbsp;22-cv-01063);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">Proof of being a Current Tactile Shareholder as of the Record Date, June&nbsp;6, 2024;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
date(s)&nbsp;you acquired your Tactile shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
statement of your position regarding the matters to be heard at the Settlement Hearing, including the grounds for each objection or the
reasons you desire to appear and be heard;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notice
of whether you intend to appear at the Settlement Hearing (you are not required to appear);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Copies
of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement
Hearing and the subject(s)&nbsp;of their testimony; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
identities of any cases, by name, court, and docket number, in which the objector or his, her, or its attorney has objected to a settlement
in the last three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>12
</SUP></FONT>&ldquo;Litigation Demand&rdquo; means the demand served on Tactile and/or members of its Board of Directors on behalf of
stockholder Cory Griffin, dated September 2, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only Current Tactile Shareholders
who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless
the Court orders otherwise. If you wish to object to the proposed Settlement, you must file the written objection described above with
the Court on or before ___________, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any Current Tactile Shareholder
as of June&nbsp;6, 2024 who does not make his, her or its objection in the manner provided herein shall be deemed to have waived such
objection and shall be forever foreclosed from making any objection to the fairness, reasonableness or adequacy of the Settlement as incorporated
in the Stipulation and/or to the requested attorneys&rsquo; fees and expenses to Plaintiffs&rsquo; Counsel, unless otherwise ordered by
the Court, but shall otherwise be bound by the Judgment to be entered and the releases to be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may inspect the Stipulation
and other papers in the Action at the Clerk of the Court, 844 North King Street, Unit 18, Wilmington, Delaware 19801-3570, at any time
during regular business hours of each business day. You may also visit [insert link].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">PLEASE
DO NOT CALL, WRITE, OR OTHERWISE DIRECT QUESTIONS TO EITHER THE COURT OR THE CLERK'S OFFICE. Any questions you have about matters in
this Notice should be directed by telephone to Lee Squitieri (</FONT><U>lee@sfclasslaw.com</U>) at (212) 421-6492 or in writing to Squitieri&nbsp;&amp;
Fearon, LLP, 305 Broadway, 7th Floor, New York, New York 10007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">YOUR
WRITTEN OBJECTIONS MUST BE ON FILE WITH THE CLERK OF THE COURT NO LATER THAN 20 CALENDAR DAYS BEFORE THE SETTLEMENT HEARING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Court Clerk's Address is: United States District Court, District of Delaware, 844 North King Street, Unit 18, Wilmington, Delaware 19801-3570.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">YOU
ALSO MUST DELIVER COPIES OF THE MATERIALS TO COUNSEL FOR PLAINTIFF AND COUNSEL FOR TACTILE SO THEY ARE RECEIVED NO LATER THAN 20 CALENDAR
DAYS BEFORE THE SETTLEMENT HEARING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>Counsel for Plaintiff:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">Lee Squitieri</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>SQUITIERI&nbsp;&amp; FEARON, LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">305 Broadway&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">7th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, New York 10007&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">(212) 421-6492</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>Attorneys for Nominal Defendant Tactile:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Matthew Kilby (<I>pro hac vice</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Rory F. Collins (<I>pro hac vice</I>)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">Anderson Tuggle (<I>pro hac vice</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH
LLP</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">2200 Wells Fargo Center<BR>
99 South Seventh Street<BR>
Minneapolis, MN 55402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">(612) 766-7000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">matthew.kilby@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">rory.collins@faegredrinker.com<BR>
anderson.tuggle@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE DO NOT CONTACT THE COURT REGARDING THIS
NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BY ORDER OF THE COURT UNITED STATES DISTRICT COURT DISTRICT OF DELAWARE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DATED: ____________, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #030303"><B><U>EXHIBIT&nbsp;E</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES DISTRICT COURT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DISTRICT
OF </B></FONT><B>DELAWARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>JACK WEAVER, Derivatively on
    Behalf of TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Plaintiff,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">v.</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BRENT MOEN, et al.,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">Defendants,</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">-and-</P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.,</FONT></P>
    <P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Nominal Defendant.</P></TD>
    <TD STYLE="width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASE NO. </FONT>1:22-cv-01063-GBW</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[PROPOSED] PRELIMINARY APPROVAL ORDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parties to the
above-captioned consolidated shareholder derivative action (&ldquo;Action&rdquo;) have made an application, pursuant to Federal Rule&nbsp;of
Civil Procedure 23.1, for an order: (i)&nbsp;preliminarily approving the Settlement of the Consolidated Derivative Action, in accordance
with the Stipulation of Settlement dated June&nbsp;6, 2024 (&ldquo;Stipulation&rdquo; or &ldquo;Settlement&rdquo;), which, together with
the exhibits annexed thereto, sets forth the terms and conditions for the proposed Settlement and dismissal of the Action with prejudice,
upon the terms and conditions set forth therein; (ii)&nbsp;approving the form and content of the Notice to Current Tactile Shareholders;
and, (iii)&nbsp;setting the date and time for the Settlement Hearing described below;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, unless otherwise
defined herein, all capitalized terms contained herein shall have the same meanings as set forth in the Stipulation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Court has read
and considered the Stipulation and exhibits annexed thereto, and good cause appearing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE,&nbsp;IT IS
HEREBY ORDERED:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Court hereby preliminarily approves, subject to further consideration at the Settlement Hearing described below, the Stipulation of Settlement,
including the terms and conditions for settlement and dismissal with prejudice of the Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
Settlement Hearing shall be held before this Court on ____________, 2024 at ______ _.m.), to be held at ________________________________________________,
either in person, telephonically or via video, to consider and determine whether the [Proposed] Order and Final Judgment, substantially
in the form of Exhibit&nbsp;B attached to the Stipulation, should be entered: (a)&nbsp;approving the terms of the Settlement as fair,
reasonable and adequate; and (b)&nbsp;dismissing with prejudice the Action against the Defendants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Court approves, as to form and content, the notices attached as Exhibits C (the &ldquo;Notice&rdquo;) and D (the &ldquo;Summary Notice&rdquo;)
to the Stipulation, and finds that the publication of the two notices as set forth below meets the requirements of Federal Rule&nbsp;of
Civil Procedure 23.1 and due process, when distributed as agreed in the Stipulation and herein is the best notice applicable under the
circumstances and shall constitute due and sufficient notice to all Persons entitled thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Within
fourteen (14) days after the entry of the Preliminary Approval Order, Tactile shall: (i)&nbsp;publish the Summary Notice once in <I>Investor's
Business Daily</I> or a similar online publication; (ii)&nbsp;post the Notice and the Stipulation (with the exhibits hereto) on the &ldquo;Investors&rdquo;
portion of the Company&rsquo;s website; and (iii)&nbsp;file with the U.S. Securities and Exchange Commission a Current Report on Form&nbsp;8-K
attaching the Notice and this Stipulation (with the exhibits hereto). The Summary Notice and Notice shall provide a link to the Investors
portion of Tactile&rsquo;s website where the Notice and Stipulation (with the exhibits thereto) may be viewed, which link shall be maintained
through the date of the Settlement Hearing. Tactile or its insurers shall pay for the costs associated with this notice program or any
other form and manner of notice required by the Court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Tactile&rsquo;s
Counsel shall file with the Court an appropriate affidavit or declaration with respect to filing and posting the Notice and Summary Notice
within twenty-one (21) days after the entry of the Preliminary Approval Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Stipulation nor the Settlement, including any exhibits attached thereto, nor any act performed or document executed pursuant to or
in furtherance of the Stipulation or the Settlement: shall be deemed to prejudice in any way the respective positions of the Settling
Parties with respect to the Derivative Action; shall be deemed a presumption, a concession, or admission by any of the Settling Parties
of any fault, liability, or wrongdoing as to any facts, claims, or defenses that have been or might have been alleged or asserted in the
Derivative Actions or with respect to any of the claims settled in the Derivative Action or any other action or proceeding; may be construed
as, or may be used as evidence of the validity of any of the Released Claims or an admission by or against the Individual Defendants of
any fault, wrongdoing, or concession of liability; and shall not be interpreted, construed, deemed, invoked, offered, or received in evidence
or otherwise used by any person in the Derivative Action or in any other action or proceeding, except for any litigation or judicial proceeding
arising out of or relating to this Stipulation or the Settlement whether civil, criminal, or administrative, for any purpose other than
as provided expressly herein. Neither the Stipulation nor the Settlement shall be admissible in any proceeding for any purpose, except
to enforce the terms of the Settlement, and except that any of the Released Defendant Persons may file the Stipulation or any judgment
or order of the Court related hereto in order to support any and all defenses or counterclaims based on res judicata, collateral estoppel,
good faith settlement, judgment bar or reduction or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Pending
final determination by the Court of whether the Settlement should be approved, this Court preliminarily bars and enjoins plaintiff Jack
Weaver (&ldquo;Plaintiff&rdquo;), Cory Griffin (the &ldquo;Demand Shareholder&rdquo;), all other Current Tactile Shareholders, and the
Company, on behalf of themselves, from commencing, instituting, filing, intervening in, participating in (as a nominal defendant or otherwise),
receiving any benefit from, or prosecuting any of the Released Claims against any of the Released Persons. All proceedings and discovery
in the Action shall be stayed except as otherwise provided for in the Stipulation, and no party to the Action or any Current Tactile Shareholder
shall file or prosecute any action or proceeding in any court or tribunal relating to the Settlement or asserting any of the Released
Claims against the Released Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
Current Tactile Shareholders shall be bound by all orders, determinations and judgments of this Court concerning the Settlement, whether
favorable or unfavorable to Current Tactile Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
Current Tactile Shareholder may appear and show cause, if he, she or it has any reason why the terms of the Settlement of the Action should
not be approved as fair, reasonable and adequate, or why the Order and Final Judgment should not be entered thereon, provided, however,
that, unless otherwise ordered by the Court, no Current Tactile Shareholder shall be heard or entitled to contest the approval of all
or any of the terms and conditions of the Settlement, or, if approved, the Order and Final Judgment to be entered thereon approving same,
unless, no later than twenty (20) days before the Settlement Hearing, such person files with the Court a statement of objection signed
by the objector, even if represented by counsel, setting forth appropriate proof of Tactile stock ownership as of June&nbsp;6, 2024, including
the number of shares of Tactile common stock owned and the date of purchase, along with written objections, including the basis therefore,
attaching any and all documentation or evidence in support of such objection; and setting forth the identities of any cases, by name,
court, and docket number, in which the objector or his, her, or its attorney has objected to a settlement in the last three years and
copies of any papers and briefs in support of said objection to the instant settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All written objections and supporting papers must
be submitted to the Court by mailing them to, or filing them in person at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Clerk of the Court<BR>
United States District Court for the District of Delaware<BR>
844 King Street, Unit 18<BR>
Wilmington, Delaware 19801-3570</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The written objections and
supporting papers must also be delivered to counsel for Plaintiff and counsel for Tactile so they are postmarked no later than 20 calendar
days before the Settlement Hearing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Co-Lead Counsel for Plaintiff:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Lee Squitieri</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><B>SQUITIERI&nbsp;&amp; FEARON, LLP</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">305 Broadway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">7th Floor&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, New York 10007</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">(212) 421-6492</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Attorneys for Nominal Defendant Tactile:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Joseph C. Schoell (#3133)<BR>
<B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH LLP</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">222 Delaware Avenue, Suite&nbsp;1410</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">Wilmington, Delaware 19801&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(302) 467-4200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">joseph.schoell@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Matthew Kilby (<I>pro hac vice</I>)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Rory F. Collins (<I>pro hac vice</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">Anderson Tuggle (<I>pro hac vice</I>)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>FAEGRE DRINKER BIDDLE&nbsp;&amp; REATH
LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">2200 Wells Fargo Center<BR>
99 South Seventh Street<BR>
Minneapolis, MN 55402&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">(612) 766-7000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">matthew.kilby@faegredrinker.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">rory.collins@faegredrinker.com<BR>
anderson.tuggle@faegredrinker.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any Current Tactile Shareholder who does not make
an objection in the manner provided herein shall be deemed to have waived such objection and shall forever be foreclosed from making any
objection to the fairness, reasonableness or adequacy of the Settlement as incorporated in the Stipulation, unless otherwise ordered by
the Court, but shall otherwise be bound by the Order and Final Judgment to be entered and the releases to be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
attorney hired by a Current Tactile Shareholder for the purpose of objecting to the Settlement must file a notice of appearance with the
Clerk of the Court no later than _________, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Plaintiff&rsquo;s
Counsel and Defendants&rsquo; Counsel are directed to promptly furnish each other with copies of any and all objections that are served
upon them or otherwise come into their possession.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Court may, for good cause, extend any of the deadlines set forth in this order without further notice to Current Tactile Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">SO ORDERED, THIS ___ day of ___________________, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Gregory B. Williams<BR> United States District Judge</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tcmd-20240705.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaaF+bOdzZR+2YkxtmB0bbnavy8oSnh23CUdwAWm4TwI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:TCMD="http://tactilemedical.com/20240705" elementFormDefault="qualified" targetNamespace="http://tactilemedical.com/20240705">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://tactilemedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="tcmd-20240705_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="tcmd-20240705_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>tcmd-20240705_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>tcmd-20240705_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tactilemedical.com/role/Cover" xlink:href="tcmd-20240705.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://tactilemedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140203676122928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  05,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TACTILE SYSTEMS TECHNOLOGY INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001027838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1801204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3701
Wayzata Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minneapolis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">355-5100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, Par Value $0.001 Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  Y@N58EXJ[',
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MZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    "  Y@N58)!Z;HJT
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M2P$"% ,4    "  Y@N58!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #F"Y5@MW,Y([P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M #F"Y5B97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ .8+E6)$J[4QQ!   +1$  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M #F"Y5B?H!OPL0(  .(,   -              "  ;4,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ .8+E6)>*NQS     $P(   L              ( !
MD0\  %]R96QS+RYR96QS4$L! A0#%     @ .8+E6*K$(A8S 0  (@(   \
M             ( !>A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #F"
MY5@D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( #F"Y5AED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2418929d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tactilemedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tcmd-20240705.xsd</File>
    <File>tcmd-20240705_lab.xml</File>
    <File>tcmd-20240705_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2418929d1_8k.htm">tm2418929d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2418929d1_8k.htm": {
   "nsprefix": "TCMD",
   "nsuri": "http://tactilemedical.com/20240705",
   "dts": {
    "schema": {
     "local": [
      "tcmd-20240705.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tcmd-20240705_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tcmd-20240705_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2418929d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://tactilemedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2418929d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2418929d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-24-078098-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-078098-xbrl.zip
M4$L#!!0    ( #F"Y5@"(B#A+@,  /4+   1    =&-M9"TR,#(T,#<P-2YX
M<V2U5MMRVC 0?>],_T'U:\87[-(D!)))R=!AAC0=R*UYZ0A9@":VY$HR)OWZ
M2KYQ,;A 6Y[DW7/.[GIW9=I7BS  <\P%8;1C-"S' )@BYA,Z[1@/(_-ZU.WW
M#7!U^?X=4+_V!],$/8(#OP5N&#+[=,(NP%<8XA;X@BGF4#)^ 1YA$&L+ZY$
M<]!E811@B94CB]0"3<MU$3#-/70?,?49?QCV2]V9E)%HV7:2)!9E<Y@P_BHL
MQ,+]!$<2REB4:L["R7_[T6^)0"7Y!%XWD]/%D#Q/,3V+!]![04\0]D[&=_ZO
ME^&)^_UU(<//SGA,X?SMC(WHS/6Z#WYR_11^O$_Z6<BV0#,<0J":047'T/7E
MY26>Q?C4=AVG83_?#D8ISLB K45 Z.LV>./\_-Q.O06T@ER,>5!(>[9VCZ'
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ML9T[II($A(?-5T<&&8&TU@L+BPVF]/,V31A)X8G(4+EEP6JQR4)#$A +-E\
M"[D4::T7%BXW1*SE]/:3X*_98YF?%6P;H';+1J?E)B-6:4"L=/D#F-$AJ(C1
M*77]P+,[)!0OLBS"+;5('6,#FC68:>E" @8RUZ*%DDA=;[GA&5IR]#4E*'LD
MZ++\&;IZ)OBB'E^_-!)%ZH6(8E7.8BQL"'6)G?_J"&BX]=LC+640(/7:@W^'
MI(I .L0Q-;>285$_C\M-S#.R =]VZ ]Q1=!0\YJC/GT0- TT:3*5AS5/KO-
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MJE> 5NH9L;(*]+NJ!.6UV'Z_O+[I6GZ2F_4F^=<*IT1N^2]02P,$%     @
M.8+E6,R+;O!=!P  X5<  !4   !T8VUD+3(P,C0P-S U7W!R92YX;6S-G-]S
MVC@0Q]]OYOX''_=,"-!>+VERG92&#M.TR86TO;N7CK %:")+C"0'^.]/LC'E
MAR5O7KS)0T+,2MKO9V79:TF^>+=*>?1$E6927+:Z)Z>MB(I8)DS,+EM?Q^VK
M\6 T:D7:$)$0+@6]; G9>O?7K[]$]N?BMW8[&C+*D_/H@XS;(S&5;Z,O)*7G
MT4<JJ")&JK?1-\(S=T0.&:<J&LATP:FA]HNBX?/H]4FO%T?M-J#>;U0D4GV]
M'VWKG1NST.>=SG*Y/!'RB2RE>M0GL4QA%8X-,9G>UG:Z.MW\%,4O.!./Y^[7
MA&@:65Y"GZ\TNVRY=C?-+OLG4LTZO=/3;N>?SS?C>$Y3TF;"<8MIJRSE:JDJ
MUST[.^ODWY:F1Y:KB>)E&_U.Z<ZV9OLM"]CO>*+9N<[=NY$Q,7G8:YN)O!;N
MOW9IUG:'VMU>N]\]6>FD5<+/"2K)Z3V=1NZOC=ZV54-B8[M%2A,6$^["UG$F
MG8&TW=+ZFQ>>*SJ];)DX36P;O5>G;TY?NQ9^WS,RZX7MGIJYWM6*.GNM+Q35
M5)A<\(T]L%>$KHSM5#0I*W+M/\\_PXPKLNDXW:CM>EF6VA;MQ\)RXT[I$)?Q
MG@_<14,>""Y[=LY<T_AD)I\Z"666?:_O/C@:_9R$_>='WM#51!ME?2YKXF1"
M>5[_#VMS8-)IP*N2Q(.ML=JI?8M#GW9#=Z7B2*J$*LNZK(NH>"]@QYUT8]%9
M$&4K:L=SQK>QGBJ9^NAL2$B/H[N@;!/-T+RR[2?.AR$GLVJ<!R9 GET,H)5J
ML(A^H#I6;.&XU(#=LP3R[:'RK=#6,.;RW+FG,^;\=:ZX2R]U!\/C@J<($'P?
M<Z0(JD6*P)40&>'W="%5#?A]2R#O5YB\J[0A8?X[(\I0Q=<0TD?&0-BO,6%[
M%"+Q?E!$:.;X0( ?6P.)_X%ZX^'1B(1\/*><NW2."% OK[('8G^#B=VO\P6
MOWYRUW=[:8&SWRD"Q/_G2\%_I!8I G=4,9G82[H"L#\R!E(_PZ3N48C*^UHD
M4-I;4W#^@P_[0!X2ZB'3,>&%1T-[3(=Q5YA#D:/DG+4R4;'_2XD"0]\QAB)'
M24-K)#8,?) IM>=,<%3Q6T.1HR2@=2(;9GXM##-K]_S_2Y9.?CXXW6=]; 5E
MC))T^D2AL"V?- CCIC5"? \MH8Q1<LV0.!3. ZM'$3X2"5U]HNL0Z"-3*&F4
M'#,H#P7UG6(I4>LQB^L'C6-;*&R4S#(L$(7V UF-$JN*35DQ,5@/W5L$RAXE
MK03)10G!2,12+>3.X^*!S.SYN![()#BDUQ2$A@,EWWR&=)2@7"6)Q:4W?VZ8
MH-U0*"K-P7-$> $(R'PAV'O/P]Z#8T?)0VMEOA#L_>=A[\.QH^2BM3(QL0_L
MQUOU()>>&6BO,10Y2BY:(Q$3>'ZEN55W2CZQ8GU4'?6C$E#TB"EJ6"QJAR\N
M\I#>7EI">2.FJ]7B,#G?26T(_X\MZNXDJ^VAS!$3UY#0IA\P%G%W#RU\2XD.
M3*!\47+52CE-(W415I3XN^^^!10H2@):):9AGC?2S7W,I0@^CSVV@G)%R21]
MHIH>>-UR8NT]]7>^!J]@0QE6#V4TC/&[8L9Z,)!IFHG-,QK/K)C'%(H7)?T+
MRFL8]5AR%C/#Q.RSO4-4C/!JSE5V4,@HR9Y?6,.$[Q1UD:;VMCM?Q^7V&ZC;
MZ=0W\H;LH<11<KUZH;CD1UIG5#V7?T4I:!10TCZHZ*;'&1IG=MA;=WN3![=C
MQC/*'%E!6:.D?#Y1#;/](A\4<?OVQNMT(KE_>TBE(90P2H(7D-8PY#T_JO$>
MF$#!HF1VE7*0QH3K53PG8D;]JQ>J+:& 43*]D#BTL7<&&GMGSQQ[43(^GR@D
MML7:<'M&W4XXFQ'_3K)@ ? ^&TSB :E-[]_+M_RX'=TJS?T8V@_5V#VF4. X
M6R1#\II&G27,T*1P:<@$$;%-J;;[VCS9>7TI: !P]E "1:,\WO]..?\DY%*,
M*=%2T*2XU0\]X?<6@48!<0ZQ1BY*"+Y)GEE**E\(JCSG@,<4BAQQ[M C#V?M
M9;&H>7OM*5[=$2+N*P$%CSB)&!:+M#[-4.<S>Z(?B"$;#T/\?26@_!$G%,-B
MT=;/JX&]\,QD>,[\P!!*&W$I;*4T%,CCE'#^/M-,4!T<6PX,H9 1U[Q62D.!
M?)U2-;.#VD<EEV:^V=L9@NTI (6.N+(U*!4'_NKG/O)B_UN0?(4U^.T$B-B]
M(K%>NQ'';B%%<247"5$>ZB%[*'?4C95^H0V3OS5SJG;OGW)G1C9O"RUZJ"\%
MC0)*N@H5C7-MW=G)'[RT[ME!>2,FIE7"</9,91/.XB&7)'A?OF<&Y8N8A5;(
M0L'[GHA'E2U,O+Y3,J;439_H[=D&2(B %4!#@IB?/@L%SN,"F:9N,Y&,'\=S
M*UK?9B9_DZGU+_C0(%@.&AK,39P X4AW0?KG1B^:O%_?TRE5;IG" UV9][:A
MQ_!-$: X-#ZH;Q0"8Z@(TT7G2->-/>#>55M\XWZY][':(_\#4$L#!!0    (
M #F"Y5A$^VU)T!4  .IL   2    =&TR-#$X.3(Y9#%?.&LN:'1M[3UK5]K*
MVM_Y%?-RSCY;5^62( IH.8L"*E[0 M;NKKV6:T@&F!J2F D"_?7G>28))!#P
M4JQVK[>KK9#,S'._SB0>_G<R-,@#<P2WS(]_*NGLGX29FJ5SL__QSTJ[VFC\
M^=]RXG#@PC 8:HJ/R8'KVJ5,9CP>I\>YM.7T,TJQ6,Q,<$S2&U2:Q(Y3LUDE
M\_7BO*T-V)"FN"E<:FIL-LG@YMWJ]?'N;&C7,7AD*%X)@.0R2TO#77T^(3QX
M+^/=C QU8X?FO:%N,)0+:U=5]M?AX8V839BL&JL@SD A^_JI=3X?[L:/GP_-
MN XU1<]RAM0%$>)*^5163:E[H452@FF1A>![NF\]/+I.(953@G66A!.E%&]W
MJ9AQ7&<+[ Y@P@V8H>:"@0[KK5QV+P-W@X$CD>I3:L\&]ZCHRH'^C<BJ<,VQ
M#"9B1\L[D>&:-3)=9QJ/L7\S,D$X[O+2<#$RJ%.]J,U&N51SN<&&3.<:-=*:
M-<2QN]G];#Z)%L:H7DX0_'/H<M=@Y<.,]S-Q.&0N);A,BMV/^,/'9-4R76:Z
MJ<[4!H9KWK>/29=-W(PTPPS,RGA+'OY?*D6..#/T$FDS]X TZ9"5R$2?')!&
M37ZXS:K5V^OV'VKMN%*Y@A](!$FEGC@Y5[E%2F^7*;P-*'SZ8KN5V:07S,X7
M;QDH&)  ?RM#9NKPSSTR:/^V1PW!GK%2-;12W0113*NPE$.-AJFSR1F;WF;!
MG675_4*N\/1E]]7;]N5MQUOV[QJSW2-@F8 O',V0%.#3&:E:Z)))APUM@[I,
M_/WAPP>XT;J\Q)EUY+'IPB>X_'?-TD;XM6'.K/<<C+KALJ%( TSQ=.3V/H$6
MU&Z56]]M>5C"I6<L ?0-J,/$K7HKG;2WAI#7GK%,#3&Y\I?*+2&T:NVNI4^)
M<*<&^YCL@5F4B)*U7=+A0QC19&/2LH;4W/$N[ !\A_?0^G3^$$S3N0"F3TO$
MM$R&]_BDA);$'#!/^87K.C/15O$;C&H"_QVN>78X<5OHT"KBLH?JF\KNI\#
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MAR*.EX,PA^D).^X$B[06/R<!MI5>.0U=@W>$9^]@<W1-:S"YU#_TL4HYO#\
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M;9X##)T]CCV;''I.<,-/M;R4YU'._\2Z/@,QGUADH0S>2P)!8@Y@C?L1MC<
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MY3 [[AI(GD@ZO4;N8A(;3HBMI?VT. IWL(_";.\I%8EQ%Q,1&T]TX,XMU#+
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MGK8#L9.(.3^@X[O.-#H2L@/+A?]J-W\[1 "SX(;EO6FJRP;4Z 6EJMPU\ =
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M44^+PX<,AD(==#C@=T,*!SAN,\^,H3F.?X+R"$_(OXGX!<ND6H]%BFQ6X#!
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MMGP^!;4KV HX*4$PRD!J.!I@4].8VB%LU%]<Z21H;X,=&X.F32,)C DH']S
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M1R3Q%F=JY2UQQJ@%FGHA%P(K']+T&R6+_S#UU3!A$+44$4N5W]-2#G]_A79
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M#75?0)*9D3>EO0F;ER1L#G] V @?.9E-8&\ULB\NH.!7*F,T%S!P75JSX[+
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MKH]@]>K">L%0TO.-%U[PTX=+W_6"Q!N-G/5-OOI-:U\0_Y<'OVFL;_KVN ]
M@T?=-K#(LXOVN2-D(ER_L<:M?]!M+IXK;M"Q',E@Z 9)O,95+'_E0]\,=?2[
M;C#<?;!+\7#TE1/!?6#IXRA,82D@:,+HK;B=> D(FZ?#UQ82B]KB\W#J!:XO
M#*4N815K?WFV6E"8C\OBV]:A4(@:H?OR7D+WG2AJ"U-O./3E(F'\5\GJ/II=
MJWG5KM?.+QI"4=/^VX.#W<'-[M[^WLO#W8]'G]=+_D<?KGJ=R^O39J]S<2Y
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MU9LW>8EP\"S;('32X#U&S25CI4C.\P?4'K^-'_;@Z;E<#WX E^OC);M[:,#
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MK5^DJF0&Z[*9@+6/^B"Z5Y?,":?"C2N(05L 3&%DR?9<'3[H/@2PA%H:HG_
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M-7RP]\.XAG]$?+Q7]W(0GWDQ^7L#&:8Q=MQ0'&OKZ[U#,7VU,5]O40;;.M\
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M>$>S/L*^V1R5UH?H/70B7N8=,RU:V&S5I?2YCB:Q0>Z+^2+9I8<6K!+"'54
M*W4-Y-_^?E85/23THVYNT)9WX_FH'7'U=@9AS7:0[I&DIX3IN-:LN*$\G0U8
M3"-)YT:-@P,$_MFRE05L90,Y=&T@1]-.ICK-%%07N 4QU84'^G;HKO5TZ>!S
M0DRP+AD1\&T4!N-AJ)*J,Q@)+=PFP 8D9E%':,;CCXB"[G%<(TTR4#$B&\?R
MZCBHG\5TDT/%%V)^NVJ3S5&0 ;;6MKMJZV\LL_@IO+* G^4 SU2L6+L\<$NX
M)U1546,56R,7N78X6?Y19@95CLBE<(H+N75^<57H095,%R<':O-,N:*H,?B
M+S/K*$66O&AVZAQ';NK#*1HZX(/*:,0U$<D1GRX+"IM?L]2HU[(CQ9;H!"%9
M.F4&-<#DWSM</)5[0G,K[*H=JJ&IU6O</6+Q^,ZB'<^U[:KRM54X_SS&Z)#4
M"][X&QUU8 YZ_F["+W0#1B,9J:L0@37BW? <)?J&B7PCRV=,3C!UA@I#9?%Z
M5O$3.@AS1[YI[2;+1"!^DT@> ^660ZUP\34XE@HEE>Y3N0GM[83;!P]0=L'^
M1-14Q'?(.YMO@^@4W7?"<CG: ?",]W$HO('I&R481/00C4-U9N4RC5(!1DP
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M)P_?\KP'N4U[6(&OO=E$%-J+D:5DMP,]F4!GTW#(Y0HHC*=,<@0.2RD+NB:
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M !HRI@@?Y05ZDL9HJ:)+,U;%0FRQ1%(U,0-#.$2X1Q-0]U3;5FIQAWD4P?<
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MBE>9.;F*PAH)4=@#S\K6@=;%7CH%XT#C"[/$M>G;-@*^8S/@Q1,T U[\,&:
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MI'37:X2!J(!CL"QZ0)7ZZL*$'HX0()D,Y4S2LN'.1"!FX2T[,VZ0DGV2?6V
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M'Y7D:=)J5,(!*8=#%_9,)UDJE2K&EC*I+_6O4K+CS@MF:<(YTYDKGW)_3&9
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M^!0S22,*MW?C^;!T!<=6KQT<-O8=@<G&\0C'JQH*1;Z"(S:H;4#%B'4[-/I
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MYM%+Y)\H,&31<ZGB*02 LR7_,OF/'P/Y.SK( 1(Z2"K]WG8))Z7!Q]IJA#N
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M.U%) ZVSZL#\0XAEV16$8V3$,*P.TTW[E&W@GW*)F6.#@$G@8>!0V1R6G$Y
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M)30DW"]@S*$U8"?]D7419$U"G40>E,,$.C6PMWFP;DGP S/WB /M3,3!I-V
MN7V-2I\.OL#[E4NZ#B*[@>(\<K!W4P-P\/G1>#@2'QD=PBZS@%<8^TU;K,A9
MZ4^R ]!U& 8+N^^,![ " P].KX$73^@N]V'@W_0"6A"*#/ ONS'(&E-C5E@A
M] 7WC>BC,%%+=*^( DND5,E'\!;N#2]5AENZ7)IZ;4*QRTZ0]3+"SLD1XQD<
MU2(L;/8YYC-RXUT4MW?:DB6W.ARCL>I$AO,)OAA'[-V[:'!;<D.HDC!=&O#9
M4(00[EQ/U7F(7$"26A3\R J5-1/JS21J1L"XUNHDZT%C2]8<GVN6[IT5)T!
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M9"TR,#(T,#<P-2YX<V102P$"% ,4    "  Y@N58EB.O3?T*  " A@  %0
M            @ %= P  =&-M9"TR,#(T,#<P-5]L86(N>&UL4$L! A0#%
M  @ .8+E6,R+;O!=!P  X5<  !4              ( !C0X  '1C;60M,C R
M-# W,#5?<')E+GAM;%!+ 0(4 Q0    ( #F"Y5A$^VU)T!4  .IL   2
M          "  1T6  !T;3(T,3@Y,CED,5\X:RYH=&U02P$"% ,4    "  Y
M@N58Y\K,2;HD  "%T   %@              @ $=+   =&TR-#$X.3(Y9#%?
M97@Y.2TQ+FAT;5!+ 0(4 Q0    ( #F"Y5@+\A-O7Z(  .4Y!  6
M      "  0M1  !T;3(T,3@Y,CED,5]E>#DY+3(N:'1M4$L%!@     &  8
*C0$  )[S      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm2418929d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcmd-20240705.xsd" xlink:type="simple"/>
    <context id="AsOf2024-07-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001027838</identifier>
        </entity>
        <period>
            <startDate>2024-07-05</startDate>
            <endDate>2024-07-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-07-05" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-07-05" id="Fact000004">0001027838</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="AsOf2024-07-05" id="xdx2ixbrl0012">TACTILE SYSTEMS TECHNOLOGY INC</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="AsOf2024-07-05" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-07-05" id="Fact000011">2024-07-05</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-07-05" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-07-05" id="Fact000014">001-37799</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-07-05" id="Fact000015">41-1801204</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-07-05" id="Fact000016">3701 Wayzata Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-07-05" id="Fact000017">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-07-05" id="Fact000018">Minneapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-07-05" id="Fact000019">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-07-05" id="Fact000020">55416</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-07-05" id="Fact000021">612</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-07-05" id="Fact000022">355-5100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-07-05" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-07-05" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-07-05" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-07-05" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-07-05" id="Fact000027">Common     Stock, Par Value $0.001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-07-05" id="Fact000028">TCMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-07-05" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-07-05" id="Fact000030">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
